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ABSTRACT 
SYNTHESIS AND CATALYTIC EVALUATION OF NOVEL C-ALPHA-METHYL-
BETA-PROLINE ANALOGUES, AND CONCISE SYNTHETIC APPROACH TO 
NH-FMOC-S-TRITYL-C-ALPHA-METHYL CYSTEINE 
by Hari Kiran Kotapati 
August  2017 
In the field of chemistry there is a growing demand for small molecule 
organocatalysts such as amino acids, more specifically proline and its analogues, 
which could catalyze various key chemical reactions in the synthesis of several 
biologically important molecules. Even though natural proline is reported to 
catalyze various chemical reactions, its use as organocatalyst is limited mainly 
due to the solubility issues in the reaction media and high catalyst loadings, 
which is not very ideal for bulk scale manufacturing. To address these limitations 
we planned to develop unnatural analogues of proline that could catalyze the 
reactions with lower catalyst loadings and expanded solvent choice. Herein we 
disclose a novel synthetic route that utilizes enzyme porcine liver esterase and a 
novel stereoselective cyclization strategy, developed in our lab, to prepare two 
diastereomers of 5-benzyl substituted Cα-methyl-β-Proline in their optically pure 
forms. These two diastereomers were tested for their activities in both Aldol and 
Mannich reactions, an important class of carbon-carbon bond forming reactions 
between carbonyl compounds. Among them, only one diastereomer proved to be 
an excellent organocatalyst in the Mannich Reaction providing anti-selective 
products with ee of up to 99%. The catalyst also catalyzed the Aldol reaction 
 iii 
between acetone and 4-nitrobenzaldehyde in water yielding racemic mixture of 
Aldol product. 
PLE isoenzyme studies were conducted on two malonate diesters 4b and 
4c with different groups in the side chain. Isoenzymes 1 and 2 did not show any 
reactivity towards both diester substrates. Isoenzyme 5 did not show reactivity 
with substrate 4b. Whereas isoenzymes 3 and 4 showed reversal of 
diastereoselectivity with the diester 4c.  
A concise synthetic methodology, for the preparation of orthogonally 
protected Cα-Methyl cysteine has been developed. Curtius rearrangement of 
enantiomerically enriched malonate halfester from PLE hydrolysis followed by 
Fmoc protection using Titanium (IV) Isopropoxide is the key step in the synthesis 
of NH-Fmoc-S-Trityl-Cα-Methyl Cysteine. The synthesized amino acid is currently 
under investigation for its effect when incorporated into a biologically active 
polypeptide. 
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CHAPTER I - INTRODUCTION 
In recent years, the demand for chiral molecules, preferentially one 
stereoisomer, has increased significantly because two thirds of current 
prescription drugs are chiral and the majority of them are single stereoisomers.1,2 
As a result, there has been extensive ongoing research to develop efficient 
methodologies to produce optically pure chiral molecules in a very selective 
manner. Among all the strategies for synthesizing optically pure chiral molecules, 
asymmetric catalysis is found to be more efficient because it can produce chiral 
products in a quantitative yield. Asymmetric catalysis is a chemical process 
where a chiral catalyst promotes a stereoselective transformation of an achiral 
substrate to a chiral product. Stereoselective transformation is a method where 
achiral molecule reacts to form a disproportionate mixture of stereoisomers 
during the reaction process. 
In asymmetric catalysis, stereoselective transformations can be achieved 
by several different methods that include, the use of metal catalysts, the use of 
chiral auxiliaries, the use of chemical reactions that involve chiral phase transfer 
catalysts or by employing optically active compounds that occur in nature.3 On 
the basis of the catalyst being used, asymmetric catalysis can be broadly 
classified into organo-metal catalysis and bioorganic catalysis.3 In the early days, 
researchers mainly focused on the asymmetric catalysis mediated by metal ion 
containing catalysts to carry out a wide variety of chemical transformations.4-7 
However there are several disadvantages of using metal ions as catalysts in 
organic reactions. Most metal ion containing catalysts are very sensitive which 
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require them to be used under closed environments and some of them are 
expensive and also toxic.3,8 In order to overcome the problems with metal ions 
researchers have found several alternative novel bioorganic catalysts that 
include peptide based compounds, chiral quaternary ammonium compounds, 
optically active compounds isolated from natural sources, and optically active 
amino acids.9-13(Figure 1.1) Among all the alternative approaches listed above, 
researchers have mainly focused on using optically active amino acids since they 
are readily available in their optically active forms and also relatively inexpensive. 
This field of asymmetric catalysis that involves small molecule catalysts that are 
free of metal atoms has emerged into a whole new field, Organocatalysis. 
 
Figure 1.1 Examples of few organocatalysts used in asymmetric synthesis 
1.2 Amino acids in organocatalysis 
Naturally available amino acids are widely used as catalysts in the field of 
organocatalysis not only because of their ease of use but also due to the fact that 
they are readily available in their optically active forms at a reasonable price. In 
the year 2004, Pizzarello and Weber published their study on the origin of 
homochirality in prebiotic building blocks.14 In this study, an Aldol condensation 
reaction was carried out between two aldehydes to synthesize sugars, Threose 
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and Erythrose using non racemic alanine and isovaline of varying enantiomeric 
excess. The enantiomeric excess of product sugars, in the reaction, decreased 
as the amino acid with lower enantiomeric excess was used as a catalyst. This 
study suggests the prebiotic amino acids may have played an important role in 
the induction of homochirality in biological molecules. In early 1980’s Julia et al 
reported a poly-L-alanine catalyzed epoxidation of chalcones that provided 
products with up to 96% enantiomeric excess.15,16  Even though the reports of 
amino acid catalyzed asymmetric chemical transformations exist since early 
1970’s, it has been widely explored only after List and coworkers reported a 
novel intermolecular Aldol reaction catalyzed by L-proline in the year 2000.17   
1.2.1 Proline and its analogues as organocatalysts 
Amino acid catalyzed carbon-carbon bond forming reactions were 
reported four decades ago by two different research groups. In 1971, Weichert 
and coworkers reported a novel Aldol reaction involving intramolecular cyclization 
of cyclic triketones18 by optically pure aminoacids to provide optically active chiral 
bicyclic compounds that were used as starting materials in the synthesis of 
steroids.19 Hajos and Parrish also reported L-Proline catalyzed asymmetric 
transformation of tricyclic ketone to an optically active intermediate that was used 
in the synthesis of steroids.20 (Scheme 1.1) 
 
Scheme 1.1 (S)-(-)-Proline catalyzed Intramolecular Aldol Cyclization reaction 
(Weichert et al 1971 and Hajos et al 1974) 
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Proline’s use as organocatalyst has expanded to various applications in 
the field of chemistry since the report by List et al in the year 2000.17 In this work 
a direct asymmetric Aldol reaction was carried out using 30 mol% of L-Proline as 
a catalyst. Since then, Proline and its analogues have successfully been used as 
catalysts in the asymmetric synthesis causing a variety of chemical 
transfomations.21-28 Enders et al reported the preparation of Ulosonic acid 
precursors in an asymmetric fashion using L-Proline as a catalyst.29 Proline 
catalyzed α-aminoxylation reactions are also used to prepare chiral building 
blocks that are used in the synthesis of several biologically active compounds.30 
Volchkov et al used L-Proline to carry out crossed Aldol condensation of two 
aldehydes, a key step in the total synthesis of Amphidinolide V.31 An efficient 
enantioselective synthesis for HMG-CoA reductase inhibitors, Atorvastatin 
(Lipitor) and Rosuvastatin (Crestor) that involves a one pot tandem Aldol 
reaction, catalyzed by deoxyribose-5-phosphate aldolases, was reported by 
William Greenberg and co-workers.32 Steven Lenger reported the total synthesis 
of Rosuvastatin that involves the stereoselective Aldol reaction.33 Recently L-
Proline catalyzed Aldol reaction that is  a key step in the synthesis of 
prostaglandin, PGF2α has been reported.34 In this report, Aldol reaction was 
carried out between two succinaldehyde molecules in the presence of L-Proline 
catalyst to prepare a key bicyclic enal intermediate in 98% ee as shown in 
Scheme 1.2. 
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Scheme 1.2 Proline catalyzed Aldol reaction in the synthesis of prostaglandin 
PGF2α (Coulthard et al) 
Mannich reaction involves carbon-carbon bond formation in the reaction 
between carbonyl compounds and amines.35 Mannich reaction is also used as a 
key tool in the synthesis of various bioactive skeletons of several compounds that 
possess potent anticancer, antiepileptic, antituberculotic and antimalarial 
properties.36 Usually L-Proline catalyzes Mannich reactions to provide “syn” 
selective products. In 2005, Hayashi et al reported an efficient asymmetric 
synthetic strategy to prepare Nikkomycin B and BX.37 This strategy utilizes 
asymmetric Mannich reaction between furfural, propanal and an aromatic amine 
catalyzed by L-Proline. This reaction provided a syn Mannich intermediate that is 
later converted to an N-terminal amino acid moiety corresponding to Nikkomycins 
B and BX. (Scheme 1.3) 
 
Scheme 1.3 Proline catalyzed asymmetric reaction in the synthesis of 
Nikkomycins B and BX (Hayashi et al) 
L-Proline’s use as a catalyst in organic reactions is not restricted to just 
Aldol or Mannich reactions. L-Proline is also reported to catalyze a wide 
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spectrum of chemical reactions that include α-Amination23,24 and α-
oxyamination25,28 of aldehydes/ketones, asymmetric Knoevenagel/Diels alder 
reaction.27 L-Proline is also used as a co catalyst in the Morita-Baylis-Hillman 
reaction catalyzed by a peptide based catalyst.26 The above are few examples of 
other organic reactions catalyzed by L-Proline besides Aldol and Mannich 
reactions. 
1.2.1.2 Proline catalyzed asymmetric intermolecular Aldol reaction 
The Aldol reaction is one of the important classes of classic carbon-carbon 
bond forming reactions between two carbonyl compounds that often occurs in 
nature. Aldol reaction is carried out by the enzyme Aldolase in the nature. There 
are two types of Aldolases, Aldolase I and Aldolase II that catalyze an Aldol 
reaction and each one of these enzymes follow their own pathway during the 
reaction. During the Aldol reaction, Type I Aldolases usually proceed via an 
Iminium ion intermediate whereas Type II Aldolases utilize Zn2+ as a cofactor in 
the catalytic process.38,39  
There were no published reports on the Type I Aldolase mimicking metal 
free small molecule asymmetric catalyst for Aldol reaction until List et al reported 
the intermolecular Aldol reaction catalyzed by L-Proline.17 In this report, an Aldol 
reaction was carried out between aldehydes and an unmodified ketone in DMSO 
using 30 mol% of catalyst. When the Aldol reaction was performed between 
acetone and 4-nitro benzaldehyde in DMSO, (R)-Aldol product was produced in 
68% yield and 76% ee. (Scheme 1.4) 
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Scheme 1.4 L-Proline catalyzed intermolecular aldol reaction 
The mechanism for Proline catalyzed intermolecular Aldol reaction was 
proposed by List et al. In this mechanism Proline proceeds via iminium-enamine 
intermediate as shown in Scheme 1.5. The mechanism for the intermolecular 
Aldol reaction between acetone and an aldehyde, catalyzed by L-Proline, 
proposed by List et al involves six steps that account for the stereoselective 
outcome in the reaction. Amino group of L-Proline serves as a nucleophile 
(Lewi’s base) and Carboxyl group acts as a Lewi’s acid during the mechanism. In 
the carbon-carbon bond forming step of the mechanism, the enamine attacks the 
carbonyl of 4-nitro benzaldehyde from the re-face. This re-facial approach is 
responsible for the stereoselectivity that is observed in the reaction. 
 
Scheme 1.5 Enamine mechanism of L-Proline catalyzed asymmetric Aldol 
reaction 
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1.2.1.3 Proline catalyzed asymmetric Mannich reaction 
Mannich reaction is another classic example for carbon-carbon bond 
formation reaction that involves an amino compound, donor carbonyl compound 
and an acceptor carbonyl compound. This transformation results in the class of 
β-amino carbonyl compounds that have a wide range of applications in the field 
of chemistry. A condensation reaction involving three components; ammonia, 
antipyrene and formaldehyde was first reported by Mannich and Kroesche in 
1912.35 Enantioselective Mannich reaction, which involves a preformed enolate 
and a preformed imine, catalyzed by various metal based catalysts was reported 
in late 1990’s.40-46 In the year 2001, Juhl et al reported an enantio- and 
diastereoselective Mannich reaction between an α-imino ester and an activated 
carbonyl compound using chiral Lewis acids as catalysts.47 List et al reported the 
first organocatalytic asymmetric three component Mannich reaction catalyzed by 
L-Proline.48,49 In these reports an asymmetric Mannich reaction between 
acetone, 4-nitrobenzaldehyde and p-anisidine using 35 mol% L-proline as 
catalyst was reported. The catalyst loading studies performed by List and 
coworkers suggested that increased catalyst loadings of L-Proline reduced the 
reaction times significantly.49 Cobb et al designed proline analogues with 
tetrazole and acyl sulfonamide functionalities and used them in the catalysis of 
asymmetric Mannich, Aldol and nitro-Michael reactions.50 
The Mannich reaction that involves a preformed imine and an unmodified 
aldehyde catalyzed by L-Proline was reported by Barbas and coworkers in the 
year 2003.51 In this report, an α-imino ester was prepared and reacted with an 
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aldehyde in the presence of 10 mol% L-Proline to provide β substituted α-amino 
acid analogues with two contiguous stereo centers. Use of L-Proline as a catalyst 
facilitated the formation of a single diastereomer predominantly over the other in 
high enantiopurity. In this case L-Proline provided “syn” selective products in a 
diastereomeric ratio of >19:1 and an enantiomeric excess of >99%. The reaction 
between isovaleraldehyde and N-PMP protected α-imino ethyl glyoxylate favored 
the formation of “syn” product in a diastereomeric ratio of >10:1 and an 
enantiomeric excess of 87%. (Scheme 1.6) 
 
Scheme 1.6 L-Proline catalyzed Mannich reaction of isovaleraldehyde with an α-
imino ester (Barbas et al)51 
Mannich reactions catalyzed by various catalysts that provide “anti” 
selective products have also been reported.52-55 In 2006, Barbas and coworkers 
synthesized β-Proline or 3-Pyrrolidine carboxylic acid, an analogue of proline, 
and used it as a catalyst in the direct asymmetric Mannich reaction, between an 
unmodified aldehyde and a N-PMP protected α-imino ester.56 (Scheme 1.7) This 
reaction proceeded with excellent diastereo- and enantioselectivities, to provide 
“anti” selective products. The same catalyst was later used in asymmetric 
Mannich reaction between N-PMP protected α-imino ester and an unmodified 
ketone to produce “anti” selective products.57 
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Scheme 1.7 β-Proline catalyzed anti-Mannich reaction of isovaleraldehyde with 
an α-imino ester (Barbas et al)56 
Though L-proline is known to catalyze Aldol and Mannich reactions in a 
stereoselective manner, its use as an organocatalyst is limited due to poor 
solubility in organic solvents. The efficiency of L-proline as a catalyst was found 
to be lowered in less polar solvents where solubility is also a concern.12,58 Use of 
natural proline as catalyst also requires high catalyst loadings, which is not very 
ideal for bulk scale manufacturing. To address the limitations and challenges 
related to solubility and catalyst loadings of L-proline’s use as catalyst, in the 
Aldol and Mannich reactions, we had planned to develop an unnatural analogue 
of proline that could catalyze the reactions with lower catalyst loadings and 
expanded solvent choice and still provide good stereoselectivities. Even there 
are few existing reports for the synthesis of Cα-methyl-β-Proline, the unique 
approach of hydrolysis by Porcine Liver Esterase and stereoselective cyclization 
is more advantageous as it utilizes nature friendly enzyme to induce chirality in a 
very selective fashion. 
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CHAPTER II - SYNTHESIS OF (3R, 5S) AND (3S, 5S)-5-BENZYL-3-
METHYLPYRROLIDINE-3-CARBOXYLIC ACID 
2.1 Hypothesis 1 
With all available tools, developed in our group, at our disposal we can 
synthesize both diastereomers of 5-benzyl substituted Cα-methyl-β-proline 
analogue in a diastereoselective manner by utilizing a chemo enzymatic 
synthetic strategy that involves the enzyme Porcine Liver Esterase and a 
selective cyclization reaction. 
For the synthesis of 5-benzyl substituted Cα-methyl-β-proline analogue we 
chose to use relatively inexpensive and commercially available optically active L-
phenylalanine as starting material. L-Phenylalanine was transformed into a 
branched malonate diester which was then subjected to asymmetric enzymatic 
hydrolysis by Porcine Liver Esterase. The diastereomerically enriched half ester 
was then taken to stereoselective cyclization reaction sequence to provide the 
desired Cα-methyl-β-proline analogue. (Scheme 2.1) 
 
Scheme 2.1 Synthetic strategy for 5-benzyl substituted Cα-methyl-β-proline 
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2.2 Background 
2.2.1.1 Synthesis of β-Proline Analogues for Mannich Reactions 
L-Proline is used as a catalyst to carry out a broad range of chemical 
transformations that involve carbon-carbon bond formation in a stereoselective 
manner. However, L-Proline’s use as a catalyst in organocatalysis is limited due 
to the arising solubility concerns. Also high loadings of L-Proline were reportedly 
used in the reactions to facilitate the desired transformations. Most organic 
reactions, that use L-proline as catalyst, are carried out in polar solvents like 
water, methanol, DMSO and DMF. The efficiency of L-proline as catalyst was 
found to be lowered, in organic reactions involving compounds with poorer 
solubility in polar solvents.12,58 Hence, researchers have focused on designing 
unnatural analogues of proline that are more hydrophobic than natural proline 
and catalyze organic reactions in nonpolar organic solvents. However, synthesis 
of unnatural analogues of proline in an enantioselective fashion has become a 
challenging task. Seebach et al reported the synthesis of alpha substituted 
proline derivatives for the first time in 1983.59 In this work a series of α-
substituted proline derivatives were synthesized from optically active proline, 
which underwent self-reproduction of chirality, to provide enantiopure analogues 
of proline. Later, Mitsumori et al designed an analogue of β-proline and reported 
its catalytic activity in anti-Mannich reaction.56  The synthesis of the β-Proline 
analogue involves 14 steps as illustrated in Scheme 2.2 and the yields obtained 
were moderate to excellent. The synthetic strategy utilized optically pure starting 
material with anti-configuration that provided access to single stereoisomer of the 
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β-proline analogue. The synthetic sequence involves double inversion at one 
stereo center that resulted in retention of the configuration. 
 
Scheme 2.2 Synthesis of a β-Proline analogue for catalysis in anti Mannich 
reaction reported by Barbas et al56 
An enantiodivergent strategy for the synthesis of α-methyl-β-proline 
analogues was reported for the first time by Banerjee et al in our group.60 Both 
enantiomers of the β-proline analogue were prepared successfully by chemo 
enzymatic pathway in an enantioselective fashion as shown in Scheme 2.3. The 
synthetic strategy reported by Banerjee et al utilized the enzyme Porcine Liver 
Esterase (PLE) to create an all carbon quaternary center in an enantioselective 
fashion. Malonate diester was subjected to asymmetric enzymatic hydrolysis by 
Porcine Liver Esterase (PLE) to provide enantioenriched chiral half ester in 91% 
ee. This chiral half ester underwent a stereoselective cyclization process in the 
later steps to provide a γ-lactam that was transformed into a Cα-methyl-β-proline. 
Both enantiomers of Cα-methyl-β-proline were prepared successfully using a 
novel cyclization reaction. 
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Scheme 2.3 PLE mediated enantioselective synthesis of Cα-methyl- β-Proline by 
Banerjee et al 
Later, Nagata et al synthesized α-methyl-β-proline analogue and reported 
its catalytic activity in Mannich reactions.61 The catalyst provided excellent 
enantioselectivities and anti diastereoselectivities in the Mannich reactions 
involving aldehydes and cyclic ketones with preformed α-imino esters. The 
enantioselective synthetic strategy reported by Nagata et al utilizes a chiral 
phase transfer catalyst to provide an enantioenriched compound. The 
enantiopurity of this compound was further improved by single recrystallization 
using (S)-1-phenylethylamine as illustrated in Scheme 2.4. 
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Scheme 2.4 Enantioselective synthesis of Cα-methyl- β-Proline by Nagata et al 
2.3 Results and Discussion 
2.3.1 Synthesis of malonate half-ester intermediates by PLE hydrolysis-
Substrate Screening 
In the designed synthetic strategy, we utilized optically pure amino acids 
as starting materials. In the first step the amino acids Leucine and Phenylalanine 
were reduced to corresponding amino alcohols using NaBH4/I2 according to the 
reported procedure.62 Alanine, however, had to be reduced by LiAlH4 according 
the reported procedure63 because isolation of L-alaninol (2a) proved to be difficult 
from the borohydride reaction. The amino alcohol was then reacted with phthalic 
anhydride using a Dean-Stark apparatus to provide N-phthalimide protected 
amino alcohol.64,65 The protected amino alcohols 2a-c, were then transformed 
into the respective triflate compounds 3a-c, to facilitate the SN2 chemistry with 
enolate of diethyl methyl malonate. Synthesis and handling of these triflate 
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compound 3a proved to be very difficult as the triflate was very unstable and 
started to decompose quickly at room temperature. The compounds 3b and 3c 
were prepared in decent yields but the triflate 3a was unstable resulting in a yield 
of 36 %.( Scheme 2.5)    
 
Scheme 2.5 Synthesis of branched malonate half esters, (2R, 4S)-5a-c from by 
crude PLE hydrolysis 
When we had attempted to do the SN2 chemistry with the mesylate, tosylate and 
iodide of the protected amino alcohol, instead of triflate, none of the reactions 
provided the substituted product. The triflate was taken immediately to the next 
step, reaction with diethyl methyl malonate on the same day to avoid further 
decomposition and side products thereof. This reaction yielded the desired 
malonate diesters 4a-c, with a preexisting chiral center in the side chain as 
shown in Scheme 2.5. In the enzymatic hydrolysis reaction, the chiral malonate 
diesters 4a-c were subjected to asymmetric ester hydrolysis by the Porcine Liver 
Esterase enzyme to afford the mixture of diastereomeric half esters 5a-c. The 
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reaction conditions for enzymatic hydrolysis by PLE, yields and the resulted 
diastereoselectivities are tabulated in Table 2.1. 
Table 2.1  
PLE hydrolysis results of malonate diesters, 4a-c and co-solvent screens of 4c 
 
Substrate 
 
Ethanol 
(V %) 
 
CH2Cl2 
(V %) 
 
d.r 
(1H NMR) 
 
%Yield 
 
 
Major 
Product 
 
4a 
 
2.5% 
 
- 
 
8:1 
 
75 
 
(2R, 4S)-5a 
 
4b 
 
2.5% 
 
 
- 
 
6:1 
 
12 
 
(2R, 4S)-5b 
 
 
 
 
4c 
 
- 
 
0.8% 
 
3.5:1 
 
10 
 
(2R, 4S)-5c 
 
2.5% 
 
 
- 
 
4.7:1 
 
30 
 
(2R, 4S)-5c 
 
2.5% 
 
 
0.6% 
 
4.1 :1 
 
57 
 
(2R, 4S)-5c 
 
20% 
 
- 
 
3.1:1 
 
18 
 
(2R, 4S)-5c 
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PLE hydrolysis reactions were carried out in phosphate buffer of pH 7.4 
and 1.0N NaOH was dispensed into the reaction using an auto burette set up as 
the reaction progressed. The reactions were worked up and the crude products 
were isolated. 1H-NMR was obtained on the crude half esters that helped us 
determine the diastereomeric ratios. The PLE hydrolysis reactions involving 
substrates 4b and 4c appeared to be very slow and had to be stopped after 5 
days and worked up. For the optimization of the PLE hydrolysis reaction 
conditions we chose to pursue the malonate diester substrate 4c. 
The diester substrate 4c is a viscous liquid and tended to hinder proper 
stirring of the reaction media. The reaction conditions had to be optimized for 
appropriate co-solvents that would facilitate proper stirring of the reaction. To the 
reaction, 2.5 % ethanol was added as a co-solvent to the phosphate buffer to 
improve the percent diastereomeric excess of the product. In addition to ethanol, 
0.6-0.8% (Volume %) methylene chloride was added along with the diester 
substrate, 4c as a solution. Adding methylene chloride helped the substrate to 
disperse as oil globules in the reaction media. Otherwise, the substrate 4c would 
stick to the bottom of the flask and hinder the stir bar from proper stirring. 
Improper stirring of the reaction buffer resulted in the lower conversions of diester 
substrate 4c. 
In the product, (2R, 4S)-5c, the stereochemistry of the quaternary chiral 
center created from the PLE hydrolysis reaction was determined from the single 
crystal X-ray analysis data of pure diastereomer of its derivative (2S, 4S)-6c. The 
stereochemistry of the halfester 5b was assigned from the 2D-NOESY NMR data 
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of the corresponding lactam 7b, derived via a stereoselective cyclization reaction. 
The stereochemistry of the half-ester 5a derived from hydrolysis by the crude 
PLE enzyme is determined to be (2R, 4S). This assignment is derived from the 
1H NMR shifts of the ethyl group of the ester. The protons of the methyl and 
methylene units in the major diastereomeric half esters (2R, 4S)-5b-c are further 
down field compared to those of the minor diastereomeric half-esters (2S, 4S)-5b 
and (2S, 4S)-5c as illustrated in the 1H NMR spectra below. 
 
Figure 2.1 1H NMR data for stereochemistry assignment at the quaternary chiral 
center in half-ester 5a 
2.3.2 PLE Isoenzyme studies of malonate diester substrates, 4b and 4c 
For the last three decades PLE has been a valuable bio catalytic tool in 
organic synthesis. PLE is used in a variety of asymmetric chemical 
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transformations that involve different substrates providing stereoselective 
products very efficiently.66-69   These enzymatic hydrolysis reactions usually utilize 
buffer as reaction media and titrate standardized sodium hydroxide into the 
reaction as the reaction progresses. PLE is known to catalyze the reactions 
involving malonate diesters causing asymmetric hydrolysis to provide optically 
enriched chiral half ester synthons in a stereoselective manner.70-72 These chiral 
synthons are used as valuable materials for the synthesis of several biologically 
important compounds.73-78 
Our research group has been very successful in utilizing the enzyme PLE 
to prepare the optically active chiral synthons from prochiral malonate diesters. 
These chiral synthons were used in the preparation of several unnatural α, β, γ 
and δ amino acids that have a methyl substituent at the Cα position of the back 
bone.60,79-81 For our synthetic purposes we utilize the crude PLE enzyme to 
perform the asymmetric enzymatic hydrolysis of the malonate diesters. In some 
cases adding ethanol as a co-solvent significantly improved the enantioselectivity 
of the product in the hydrolysis reaction.82 Crude PLE is a mixture of at least six 
different isoenzymes in various proportions. Each one of these isoenzymes could 
provide different yields and selectivities from that of the crude enzyme.83 
After observing the asymmetric ester hydrolysis results by crude PLE, we 
looked into the isoenzymes of PLE to see if any of the isoenzymes would provide 
better selectivities or conversions for our synthetic purposes. For this purpose, 
we chose to pursue the asymmetric hydrolysis of the diethyl methyl malonate 
diester substrates 4b and 4c. The diesters that were chosen for our enzymatic 
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hydrolysis reactions have a preexisting chiral center in the side chain and also a 
bulky phthalimide group. To the extent of our knowledge, these substrates are 
the very first ones of this type to be investigated for hydrolysis by PLE. Recently, 
malonate diester with a preexisting chiral center has been utilized for PLE 
hydrolysis to create the product in a diastereoselective fashion.84 
When diesters 4b and 4c are subjected to enzymatic hydrolysis, it is 
possible for the reaction to produce only two compounds (2R, 4S)-5b-c and (2S, 
4S)-5b-c that are diastereomers to one another. (Scheme 2.6) This is due to the 
fact that our starting materials are optically pure and the stereochemistry at the 
preexisting chiral center is already set to be “S”. 
 
Scheme 2.6 PLE isoenzyme hydrolysis reaction studies of malonate diesters 4b 
and 4c 
The PLE hydrolysis reactions were set up in phosphate buffer, pH 7.4 and 
the reactions were carried out on a titrator instrument using an auto burette set 
up that dispenses 1.0N NaOH into the reaction as the reaction progressed. The 
enzyme was added to the reaction as a suspension in 3.0 M Ammonium Sulfate. 
The reactions with substrate 4b were allowed to proceed for 7 days and then 
worked up. Among the six different isoenzymes of PLE (1-6), PLE 1, 2 and 5 did 
not show any conversion of diester 4b to the product. With the use of 
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isoenzymes there is a slight improvement in the yields of substrate 4b, however 
the stereoselectivity was not improved. The percent diastereomeric ratios were 
determined from 1H-NMR of the crude product. The results of the isoenzyme 
studies are tabulated below. (Table 2.2) 
Table 2.2  
PLE isoenzyme studies of malonate diester substrate, 4b 
Enzyme  d.r. 
(
1
H NMR) 
% Yield Major 
Diastereomer 
Minor 
Diastereomer 
PLE 1 - - - - 
PLE 2 - - - - 
PLE 3 5.7:1 24 (2R, 4S)-5b (2S, 4S)-5b 
PLE 4 1.3:1 13 (2R, 4S)-5b (2S, 4S)-5b 
PLE 5 - - - - 
PLE 6 11:1 25 (2R, 4S)-5b (2S, 4S)-5b 
Crude PLE 6:1 12 (2R, 4S)-5b (2S, 4S)-5b 
 
The reactions of substrate 4c was allowed to proceed for 5 days. The 
conversion with substrate 4c did not improve with any of the six isoenzymes 
compared to that of the crude PLE enzyme. Like with substrate 4b, PLE 1 and 2 
did not show any reactivity with diester substrate 4c. To our surprise PLE 
isoenzymes 3 and 4 showed a reversal in the diastereoselectivity of the product 
half ester. However, the yields of the reactions with isoenzymes did not seem to 
improve at all when compared to that of the crude PLE enzyme. The reversal of 
selectivity was determined from the 1H-NMR shifts of the product half ester. We 
found these results to be interesting because this reversal in selectivity would 
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help us alter the stereochemistry at quaternary chiral carbon of the half ester 
without any additional chemical transformations.60 The yields and 
diastereoselectivities of the PLE isoenzyme studies with malonate diester 
substrate 4c are tabulated below (Table 2.3) 
Table 2.3  
PLE isoenzyme studies of malonate diester substrate, 4c 
Enzyme  d.r. 
(
1
H NMR) 
% Yield Major 
Diastereomer 
Minor 
Diastereomer 
PLE 1 - - - - 
PLE 2 - - - - 
PLE 3 3.8:1 30 (2S, 4S)-5c (2R, 4S)-5c 
PLE 4 3.4:1 20 (2S, 4S)-5c (2R, 4S)-5c 
PLE 5 4.2:1 13 (2R, 4S)-5c (2S, 4S)-5c 
PLE 6 4.1:1 10 (2R, 4S)-5c (2S, 4S)-5c 
Crude PLE 4.1:1 57 (2R, 4S)-5c (2S, 4S)-5c 
 
The stereochemistry of the major diastereomer of the half ester 5b was 
assigned from 2D-NOESY data of the lactam 7b derived through our 
stereoselective cyclization methodology (Scheme 2.7) followed by diastereomeric 
ratio improvement. The half ester from the asymmetric hydrolysis, of the 
malonate diester 4b, by crude PLE was utilized for this purpose. 
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Scheme 2.7 Synthesis of lactam (3R, 5S)-7b, via stereoselective cyclization 
The product half ester 5b was transformed into 4-nitro benzyl ester 6b 
upon reaction with 4-nitro benzyl bromide. Compound 6b was then treated with 
hydrazine hydrate to cause stereoselective cyclization to provide lactam 7b. The 
crude lactam was then purified carefully via flash column chromatography to 
obtain essentially diastereopure lactam 7b. The diastereopure lactam 7b was 
completely characterized and the stereochemistry at the quaternary chiral center 
was determined to be “R” from the 2D-NOESY NMR experimental data. NOESY 
interactions are through space and to observe these correlations the two atoms 
or groups must be within 5 Å distance to each other. It is also essential that the 
atoms or groups must be in a restricted free rotation environment and for this 
purpose lactams are very useful.85 The key NOESY interactions that were used 
to assign the stereochemistry are shown in Figure 2.1. 
 
Figure 2.2 Specific 2D-NOESY correlations for compound (3R, 5S)-7b 
2.3.3 Synthesis of (3R, 5S)-5-benzyl-3-methylpyrrolidine-3-carboxylic acid 
The half ester (2R, 4S)-5c, from the PLE hydrolysis reaction was 
converted to (3R, 5S)-5-benzyl-3-methylpyrrolidine-3-carboxylic acid (3R, 5S)-
10c, in five steps (Scheme 2.8), via the stereoselective cyclization reaction that 
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was reported by our group.60 During this synthetic sequence the diastereomeric 
ratio of the major product was improved to 24:1 by simple recrystallization and 
absolute stereochemistry at quaternary chiral center was assigned from its X-ray 
crystal structure. 
 
Scheme 2.8 Synthesis of (3R, 5S)-5-benzyl-3-methylpyrrolidine-3-carboxylic acid 
Malonate half ester, (2R, 4S)-5c, upon reaction with 4-nitro benzyl 
bromide afforded the 4-nitro benzylic ester (2S, 4S)-6c in 67% yield and a 
diastereomeric ratio of 24:1. During the reaction work up with diethyl ether, the 
major diastereomer product (2S, 4S)-6c precipitated out of the crude reaction 
mixture as a white solid. The improvement in the diastereomeric ratio was 
observed from the 1H-NMR data. Crystals of diastereopure compound (2S, 4S)-
6c were developed for X-ray crystallography analysis by solvent diffusion 
technique. Single X-ray crystal analysis data revealed the stereochemistry at the 
new quaternary chiral center to be “S”. (Figure 2.2) Based on this stereochemical 
assignment, the quaternary chiral center in the malonate half ester (2R, 4S)-5c 
from the PLE hydrolysis reaction is determined to be in “R” configuration due to 
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the changing priorities of the functional groups. Absolute stereochemical 
assignment was made relative to the preset chiral center, adjacent to the 
phthalimide nitrogen, which is derived from the optically pure amino acid starting 
material. 
 
Figure 2.3 Single X-ray crystal structure of (S)-1-ethyl 3-(4-nitrobenzyl) 2-((S)-2-
(1,3-dioxoisoindolin-2-yl)-3-phenylpropyl)-2-methylmalonate, (2S, 4S)-6c  
In the next step of synthetic sequence, diastereopure compound (2S, 4S)-
6c was treated with hydrazine hydrate in methanol. The compound was not 
completely soluble in pure methanol. Hence methylene chloride was added to 
facilitate the solubility of the 4-nitrobenzyl ester, (2S, 4S)-6c in methanol. The 
reaction was heated to reflux the solvent and the reaction went to completion 
after 5 days. The chemistry of this reaction was previously reported by Banerjee 
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et al in the synthesis of Cα-methyl-β-proline.60 In this reaction, hydrazine cleaves 
off the phthalimide resulting in the formation free amine. Under basic conditions 
this free amine reacts with the more electrophilic carbonyl to cause cyclization. 
The cyclization is controlled towards one specific carbonyl by installing more 
electron withdrawing 4-nitro benzyl group on the carbonyl moiety. In our case the 
selective cyclization happened predominantly towards the 4-nitro benzylic ester 
side and no trace of cyclization towards ethyl ester was observed. However, 
even under harsh refluxing conditions the reaction appeared to be very slow and 
took 5 days to go to completion. The reason for the longer reaction times in this 
reaction could be due to the steric congestion created by the bulky benzylic 
substituent adjacent to the nitrogen of phthalimide group. 
The cyclization product (3R, 5S)-7c, was then reacted with benzyl bromide 
in the presence of sodium hydride to create an N-benzylated product according 
to the reported procedure by Banerjee et al. This reaction, however yielded a 
complex mixture of the products that included the N-benzylated product with the 
ethyl ester hydrolysed to acid. After our unsuccessful attempt to N-benzylate the 
lactam (3R, 5S)-7c, we chose to avoid the N-benzyl protection step. This 
approach facilitated the reduction of the lactam to amine in decent yields and at 
the same eliminated two steps (N-benzyl protection and deprotection) of the 
proposed synthetic strategy.  
Upon reaction with Lawesson’s reagent, the lactam (3R, 5S)-7c, was 
transformed into a thio lactam (3S, 5S)-8c in 93% yield.86,87  By utilizing Raney Ni 
under hydrogen atmosphere, the thio lactam (3S, 5S)-8c, was then reduced to 
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the corresponding amino ester (3R, 5S)-9c in 51% yield.88,89 In the final step the 
amino ester (3R, 5S)-9c was dissolved in 6.0N HCl and refluxed for 24 hrs to 
hydrolyze the ethyl ester and provide the amino acid (3R, 5S)-10c as its HCl salt 
in a quantitative yield. The amino acid was then purified via an ion exchange 
chromatography using DOWEX 50X8-200 resin to provide the amino acid (3R, 
5S)-10c, in its zwitterionic form in a quantitative yield. The synthesis of (3R, 5S)-
5-benzyl-3-methylpyrrolidine-3-carboxylic acid was achieved in five steps in good 
overall yield. Avoiding N-benzyl protection of the lactam (3R, 5S)-7c, allowed for 
the elimination of two steps in the proposed synthetic strategy while providing 
reasonable yields during the process. 
2.3.4 Synthesis of (3S, 5S)-5-benzyl-3-methylpyrrolidine-3-carboxylic acid 
After investigating the catalytic activity of the designed β-proline analogue, 
(3R, 5S)-10c in Aldol and Mannich reactions we had decided to prepare the β-
proline analogue with alternate stereochemical configuration at the quaternary 
chiral center. For this purpose we chose to perform a preliminary experiment 
where we took the diethyl methyl malonate diester substrate and treated with 
hydrazine hydrate in presence of methanol. Hydrazine cleaved off the 
phthalimide liberating the free amine. The free amine, under basic conditions 
went on to react with the carbonyls of both ethyl esters causing cyclization. In this 
reaction we had expected to see a 1:1 mixture of diastereomers. Surprisingly the 
reaction yielded mixture of diastereomers in a ratio of 1.3:1 with (3R, 5S)-7c 
being the major diastereomer. (Scheme 2.9)  
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Scheme 2.9 Synthesis of (3S, 5S)-ethyl 5-benzyl-3-methyl-2-oxopyrrolidine-3-
carboxylate from malonate diester 4c. 
We have then tried resolving the diastereomers by flash column 
chromatography to isolate (3S, 5S)-7c so that we could proceed with the 
synthesis to the desired amino acid. Upon trying several solvent conditions we 
were able to find a solvent system that provided a reasonable resolution of the 
diastereomers. After flash column purification of the crude reaction mixture, the 
desired lactam (3S, 5S)-7c was isolated in 29% over all yield from the malonate 
diester substrate 4c. The product lactam (3S, 5S)-7c was identified from 1H-NMR 
chemical shifts as it has different chemical shifts from its diastereomer (3R, 5S)-
7c. The diastereopure lactam (3S, 5S)-7c was also identified and the 
stereochemistry at the quaternary chiral center on the lactam was confirmed by 
single X-ray crystal data analysis. X-ray quality crystals of the lactam were 
developed by solvent diffusion technique using ether/methylene chloride mixture. 
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X-ray data showed that the carbonyl of the ethyl ester and the benzyl group on 
the pyrrolidine core are in two different planes (Figure 2.3). 
 
Figure 2.4 Single X-ray crystal structure of (3S, 5S)-ethyl 5-benzyl-3-methyl-2-
oxopyrrolidine-3-carboxylate, (3S, 5S)-7c 
The method to prepare the lactam (3S, 5S)-7c from malonate diester 4c 
(Scheme 2.9) provided the desired diastereomer in a decent yield of 29%, 
considering the fact that this method involves separation of diastereomers. We 
then decided to perform PLE isoenzyme studies to see if any of the six different 
isoenzymes would provide the desired diastereomeric half ester (2S, 4S)-5c in 
an asymmetric fashion. To our surprise, PLE Isoenzymes 3 and 4 provided the 
desired half ester in a decent diastereomeric excess. The half ester from PLE 3 
hydrolysis was taken to the next steps of stereoselective cyclization methodology 
and then transformed into (3S, 5S)-5-benzyl-3-methylpyrrolidine-3-carboxylic 
acid, (3S, 5S)-10c as shown in Scheme 2.10. The half ester (2S, 4S)-5c (d.r = 
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5.7:1) from PLE Isoenzyme 3 hydrolysis was converted to 4-nitro benzylic ester 
(2R, 4S)-6c (d.r = 5.7:1) in 91% yield. At this point attempts were made to 
improve the diastereomeric ratio and none of them were successful. The crude 
product looked essentially pure and did not require any further purification. 
 
Scheme 2.10 Synthesis of (3S, 5S)-5-benzyl-3-methylpyrrolidine-3-carboxylic 
acid 
4-Niro benzyl ester compound, (2R, 4S)-6c, was subjected to phthalimide 
cleavage by treatment with hydrazine hydrate to produce free amine. The free 
amine then went to cyclize on to the carbonyl containing 4-nitro benzyl group 
predominantly through a stereoselective cyclization reaction mechanism.60 The 
crude material was then purified carefully via flash column chromatography to 
further improve the diastereomeric ratio of the cyclized product (3S, 5S)-7c to 
>24:1. The lactam (3S, 5S)-7c was reacted with Lawesson’s reagent to provide 
thiolactam (3R, 5S)-8c in 99% yield. The thiolactam obtained was then reduced 
with Raney-Ni under H2 atmosphere to provide corresponding amine (3S, 5S)-9c 
in 59% yield. The amino ester (3S, 5S)-9c was refluxed in 6.0N HCl to provide 
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the amino acid (3S, 5S)-10c as a hydrochloride salt. The amino acid HCl salt was 
then subjected to ion exchange chromatography using DOWEX 50X8-200 resin 
to provide the amino acid in its zwitterionic form as a white solid in quantitative 
yield. 
2.4 Experimental Methods 
All anhydrous solvents were obtained by passage through a column of 
activated silica. Flash column chromatography was performed using SiliaFlash® 
P60 40-63µm (230-400 mesh) silica gel. NMR experiments were performed on a 
Bruker 400 MHz NMR instrument and chemical shifts were reported with 
reference to either TMS (for CDCl3) or residual solvent proton peak (for CD3OD). 
Infrared analysis was performed on a Thermo Nicolet nexus 470 FT-IR 
instrument. Melting point analysis was performed using a Thomas-Hoover “Uni-
Melt” Melting Point Apparatus. High Resolution mass spectra were obtained 
using positive electrospray ionization on a Bruker 12 Tesla APEX -Qe FTICR-MS 
with an Apollo II ion source. Triflic anhydride was freshly distilled on phosphorous 
pentoxide under Nitrogen atmosphere before use according to the reported 
procedure.90 
1a, (S)-2-aminopropan-1-ol: 
6.291g (165.8 mmol) of Lithium Aluminum Hydride was suspended in 125 
mL of anhydrous THF in a 500 mL three neck flask at 0 oC and under N2 
atmosphere. To the above flask, 10.0g (112.0 mmol) of L-Alanine was added in 
portions over a period of 10 minutes. Reaction appeared to be highly exothermic 
and once the bubbling subsided, reaction was brought to room temperature. The 
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reaction mixture was heated to reflux the solvent overnight for 16 hrs. Then the 
reaction was cooled to room temperature and 100 mL diethyl ether was added. 
To this reaction mixture was added 4.7 mL water, 4.7 mL methanol followed by 
14 mL water in the same order. Contents were transferred to a 500 mL beaker 
and the reaction flask was rinsed with methanol (25 mL). The contents in the 
beaker were stirred for 30 minutes. Then the reaction mixture was filtered 
through celite and the resulted white cake was washed with diethyl ether (6 x 30 
mL). All the organic portions were dried over sodium sulfate, filtered and the 
solvent was removed under vacuum to provide 2.3 g (30.62 mmol) of product as 
yellow liquid in 27% yield. The isolation of product was very difficult from the 
aqueous portion of the reaction mixture. The crude product appeared to be 
essentially pure and the 1H-NMR data obtained corresponded to that of the 
product.91 1H NMR (400 MHz, MeOD) δ 3.46 (dd, J = 10.7, 4.7 Hz, 1H), 3.29 (dd, 
J = 10.7, 7.3 Hz, 1H), 2.91 (dqd, J = 13.1, 6.5, 4.8 Hz, 1H), 1.07 – 1.02 (m, 3H). 
1b, (S)-2-amino-4-methylpentan-1-ol: 
Reduction of L-Leucine was performed using sodium borohydride and 
iodine and the reaction was worked up according to the procedure reported for 
1c. Materials used for this reaction are L-leucine (3.0 g, 22.87 mmol), sodium 
borohydride (2.16g, 57.175 mmol), iodine (5.96g, 23.5 mmol) and anhydrous 
THF (40 mL). 2.43 g (20.75 mmol) of crude product was isolated after the work 
up as a clear viscous liquid in 91% yield. 1H-NMR data of this crude material 
suggested that compound is pure.93 1H-NMR (400 MHz, CDCl3) δ 3.70 – 3.59 (m, 
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1H), 3.33 (dd, J = 10.9, 8.0 Hz, 1H), 3.02 (qd, J = 7.1, 3.7 Hz, 1H), 2.96 – 2.85 
(m, 4H), 1.78 – 1.63 (m, 1H), 1.26 (t, J = 7.1 Hz, 2H), 0.98 – 0.86 (m, 7H). 
1c, (S)-2-amino-3-phenylpropan-1-ol: 
22.10 g (0.5842 mol) of sodium borohydride was suspended in 800 mL of 
anhydrous THF in a 2.0 L three neck flask at 0 oC under N2 atmosphere. The 
reaction flask was connected to an overhead stirrer and also an addition funnel. 
40.00 g (0.2421 mol) of L-phenylalanine was added to the above flask in portions 
over a 10 minute period. Then 61.96 g (0.2441 mol) of iodine was dissolved in 
150 mL anhydrous THF and added to the above reaction flask at 0 oC via an 
addition funnel over a period of 3 hrs. Reaction mixture was stirred at room 
temperature for 45 minutes and then heated to reflux the solvent over the night. 
After refluxing for 18 hrs the reaction mixture was cooled to room temperature 
and methanol (approximately 50 mL) was added slowly to the flask under ice 
until the reaction mixture became clear. Reaction mixture was allowed to stir for 
30 minutes at room temperature. Then the solvent was removed under vacuum 
to provide a white slurry. This slurry was dissolved in 200 mL of 20% KOH and 
the resulting solution was stirred for 4.5 hrs at room temperature under N2 
atmosphere. Then the organic contents were extracted with dichloromethane (4 x 
200 mL). All organic portions were combined, dried over magnesium sulfate, 
filtered and the solvent was removed under vacuum to provide crude product. 
22.365g (0.148 mol) of the pure product was recrystallized from toluene as a 
white solid in 61% yield. 1HNMR data of the product matches to that of the 
product.92 1H NMR (400 MHz, CDCl3) δ 7.35 – 7.27 (m, 2H), 7.26 – 7.16 (m, 3H), 
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3.64 (dd, J = 10.5, 3.9 Hz, 1H), 3.38 (dd, J = 10.5, 7.2 Hz, 1H), 3.20 – 3.05 (m, 
1H), 2.80 (dd, J = 13.5, 5.3 Hz, 1H), 2.53 (dd, J = 13.5, 8.6 Hz, 1H), 1.65 (s, 1H). 
2a, (S)-2-(1-hydroxypropan-2-yl)isoindoline-1,3-dione: 
1.0 g (13.31 mmol) of 2a was placed in a single neck round bottom flask. 
15 mL of freshly distilled toluene was added to this flask and contents were 
stirred for 5 minutes. 0.186 mL (1.331mmol) of triethylamine was added and 
contents were continued to stir for another 10 minutes under N2 atmosphere at 
room temperature. Then 1.971 g (13.31 mmol) of phthalic anhydride was added 
to the above flask. The reaction flask was connected to a Dean-Stark apparatus 
and the reaction flask was heated to 135 oC using an oil bath set up for 3 hrs. 
Then the reaction mixture was cooled and 20 mL of ethyl acetate was added to it. 
At this point the reaction mixture was dark brown colored. The organic portion 
was washed with 5% sodium bicarbonate (3 x 20 mL), 1.0M HCl (2 x 15 mL), 
Water (2 x 15 mL) and saturated solution of sodium chloride (2 x 20 mL) in the 
same order. The organic portion was dried over magnesium sulfate, filtered and 
the solvent was removed under vacuum to provide crude material as a light 
yellow solid. The crude material was purified by flash column chromatography 
(30% ethyl acetate/70% chloroform, Rf = 0.37) to provide 1.58g (7.70 mmol) of 
pure product in 58% yield. 1H and 13C NMR data corresponded to that of the 
product.94 1H NMR (400 MHz, CDCl3) δ 7.91 – 7.64 (m, 4H), 4.51 (pd, J = 7.2, 
3.7 Hz, 1H), 4.03 (ddd, J = 11.8, 8.8, 7.5 Hz, 1H), 3.89 (dt, J = 11.8, 3.8 Hz, 1H), 
2.72 (dd, J = 8.8, 3.9 Hz, 1H), 1.45 (d, J = 7.1 Hz, 3H). 13C NMR (101 MHz, 
CDCl3) δ 168.96, 134.10, 131.93, 123.32, 64.29, 49.38, 14.79. 
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2b, (S)-2-(1-hydroxy-4-methylpentan-2-yl) isoindoline-1,3-dione: 
Reaction was set up and worked up according to the procedure reported 
for 2a. Materials used for this reaction are 1b (2.43 g, 20.74 mmol), phthalic 
anhydride (3.07 g, 20.74 mmol), triethylamine (0.3 mL) and freshly distilled 
toluene (30 mL). 4.04 g (79%) of crude product isolated was analyzed by 1H 
NMR and determined to be pure enough to proceed to the next step. 1H NMR 
(400 MHz, CDCl3) δ 7.87 – 7.79 (m, 2H), 7.76 – 7.68 (m, 2H), 4.53 – 4.41 (m, 
1H), 4.04 (dt, J = 11.6, 7.5 Hz, 1H), 3.86 (dd, J = 11.6, 3.1 Hz, 1H), 2.58 (d, J = 
4.8 Hz, 1H), 2.06 – 1.91 (m, 1H), 1.59 – 1.46 (m, 2H), 0.98 – 0.90 (m, 6H). 
2c, (S)-2-(1-hydroxy-3-phenylpropan-2-yl)isoindoline-1,3-dione: 
Reaction was set up and worked up according to the procedure reported 
for 2a. Materials used for this reaction are 1a (4.0 g, 26.45 mmol), phthalic 
anhydride (3.90 g, 26.33 mmol), triethylamine (0.37 mL) and freshly distilled 
toluene (50 mL). This reaction afforded 6.15g (21.86 mmol) of product which is 
essentially pure in 83% yield. NMR analysis was performed and the data 
corresponds to that of product.64 1H NMR (400 MHz, CDCl3) δ 7.83 – 7.65 (m, 
4H), 7.24 – 7.11 (m, 5H), 4.64 (ddd, J = 15.1, 8.0, 3.5 Hz, 1H), 4.14 – 4.00 (m, 
1H), 3.94 (dd, J = 11.9, 3.4 Hz, 1H), 3.22 (t, J = 7.0 Hz, 2H), 2.77 (s, 1H). 13C 
NMR (101 MHz, CDCl3) δ 168.95, 137.41, 134.10, 131.66, 129.08, 128.54, 
126.69, 123.34, 62.90, 55.24, 34.82. 
3a, (S)-2-(1,3-dioxoisoindolin-2-yl)propyl trifluoromethanesulfonate: 
0.760 g (3.70 mmol) of 2a, was placed in a 100 mL three neck flask under 
N2 atmosphere along with 20 mL of anhydrous methylene chloride. The reaction 
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flask was cooled to -25 oC and 0.592 mL (4.25 mmol) of triethylamine was added 
to it. The contents of the flask were allowed to stir for 10 minutes.  Then 0.72 mL 
(1.198 g, 4.25 mmol) of freshly distilled triflic anhydride was added as a solution 
in 8 mL anhydrous methylene chloride to the above reaction flask under N2 
atmosphere at -25 oC. Reaction was continued to stir under these conditions for 
one hour. Then solvent was removed under vacuum to provide crude material as 
orange colored syrup. The crude reaction mixture was purified by a silica gel plug 
chromatography using methylene chloride/hexanes (50/50) as solvent to provide 
0.440 g of pure product in 35% yield. 1H NMR was obtained on the pure product 
and it matches to that of the product.95 The product was very unstable and 
started to decompose at room temperature. Hence it was taken to the next step 
immediately on the same day. 1H NMR (300 MHz, CDCl3) δ 7.94 – 7.70 (m, 4H), 
5.09 (t, J = 9.7 Hz, 1H), 4.87 – 4.72 (m, 1H), 4.67 (dd, J = 10.1, 5.1 Hz, 1H), 1.54 
(d, J = 7.1 Hz, 3H). 
3b, (S)-2-(1,3-dioxoisoindolin-2-yl)-4-methylpentyl trifluoromethanesulfonate: 
4.776g (19.31 mmol) of 2b was dissolved in 25 mL of anhydrous 
methylene chloride in a 250 mL three neck round bottom flask under N2 at 0 oC. 
2.7 mL of triethylamine was added to the reaction flask and reaction was 
continued to stir for 15 minutes. Freshly distilled triflic anhydride (5.994 g, 21.245 
mmol) was added to the above reaction flask, slowly in a dropwise fashion, as a 
solution in 30 mL anhydrous methylene chloride via an addition funnel at 0 oC 
and under N2 atmosphere. After the addition was complete, the reaction was 
continued to stir for one hour at 0 oC under inert atmosphere. The reaction 
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mixture was then passed through a silica plug under vacuum and the silica bed 
was rinsed with additional anhydrous methylene chloride. The solvent was then 
removed under vacuum to provide 6.64g (17.5 mmol) of product as clear liquid, 
that is essentially pure as determined from 1H NMR. (%yield = 91%)  The 
compound 3b appeared to be unstable as it started to decompose upon standing 
at room temperature. Hence it was taken on to the next step immediately on the 
same day to avoid further decomposition.1H NMR (400 MHz, CDCl3) δ 7.93 – 
7.82 (m, 2H), 7.81 – 7.73 (m, 2H), 5.07 (t, J = 10.0 Hz, 1H), 4.78 – 4.69 (m, 1H), 
4.64 (dd, J = 10.3, 4.6 Hz, 1H), 2.13 (ddd, J = 13.3, 10.7, 4.1 Hz, 1H), 1.57 – 
1.40 (m, 2H), 0.95 (dd, J = 8.8, 6.3 Hz, 6H). 
3c, (S)-2-(1,3-dioxoisoindolin-2-yl)-3-phenylpropyl trifluoromethanesulfonate: 
Reaction was set up and worked up according to the procedure reported 
for 3b. The materials used in this reaction were alcohol 2c (20.0 g, 71.09 mmol), 
freshly distilled triflic anhydride (22.065g, 78.20 mmol), triethylamine (9.92 mL, 
71.09 mmol)  and anhydrous methylene chloride (330 mL). After purification by 
silica gel plug chromatography 24.65 g (59.64 mmol) of essentially pure product 
was obtained in 84% yield. 1H NMR data was obtained on the product and it 
matched to that of the product.96 1H NMR (400 MHz, CDCl3) δ 7.84 – 7.66 (m, 
4H), 7.28 – 7.13 (m, 5H), 5.17 (t, J = 9.9 Hz, 1H), 4.93 (tdd, J = 9.5, 6.9, 4.6 Hz, 
1H), 4.71 (dd, J = 10.4, 4.6 Hz, 1H), 3.25 (ddd, J = 20.8, 13.9, 8.2 Hz, 2H). 
4a, (S)-diethyl 2-(2-(1, 3-dioxoisoindolin-2-yl) propyl)-2-methylmalonate:  
0.144 g (6.02 mmol) of NaH (60% by weight in mineral oil) was placed in a 
50 mL, three neck round bottom flask at 0 oC under N2 atmosphere. NaH was 
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washed with pentane (2 X 2 mL) to remove mineral oil and pentane layers were 
decanted. 4 mL anhydrous THF was added to the reaction flask and contents 
were stirred for 5 minutes. 0.523 g (3.01 mmol) of diethyl methylmalonate was 
added to the above reaction flask slowly in a dropwise manner using a gas tight 
syringe as a solution in 3 mL anhydrous THF. The reaction contents were stirred 
for 10 minutes at 0 oC under N2 atmosphere and then brought to room 
temperature. Reaction mixture was continued to stir for 30 minutes at room 
temperature under N2 atmosphere. The above enolate, under N2 atmosphere, 
was carefully dripped into a 50 mL single neck round bottom flask containing 
0.460 g (1.36 mmol) of 3a dissolved in 7mL of anhydrous THF at 0 oC using a 
Teflon canula. The drip rate was controlled by the Nitrogen flow to the reaction 
flask. The reaction mixture was allowed to stir at 0 oC for one hour, then brought 
to room temperature and left to stir over night at room temperature under N2 
atmosphere. After stirring overnight, solvent was removed on the rotovapor and 
20 mL water was added to the crude reaction mixture. Organic contents were 
extracted with diethyl ether (3 x 20 mL). All the ether portions were combined and 
washed with water (3 x 25 mL) followed by brine (1 x 25 mL). Ether portion was 
then dried over MgSO4 and solvent was removed under vacuum to afford crude 
product which was later purified by gradient flash column chromatography (10% 
ethyl acetate/90% hexanes to 15% ethyl acetate/85% hexanes) to provide 0.180 
g (0.500 mmol) of pure 4a as light yellow liquid in 37% yield. IR (cm-1): 2927, 
1727, 1707. [α]D27 = -29.0 (c = 0.93, CHCl3). 1H NMR (400 MHz, CDCl3): δ 7.89 – 
7.61 (m, 4H), 4.63 – 4.46 (m, 1H), 4.24 – 4.04 (m, 2H), 3.92 – 3.61 (m, 2H), 3.00 
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(dd, J = 15.0, 10.3 Hz, 1H), 2.21 (dd, J = 15.0, 3.5 Hz, 1H), 1.50 (d, J = 7.0 Hz, 
3H), 1.47 (s, 3H), 1.21 (t, J = 7.1 Hz, 3H), 1.10 (t, J = 7.1 Hz, 3H). 13C NMR (101 
MHz, CDCl3) δ 172.16, 171.55, 168.01, 133.91, 131.97, 123.04, 61.47, 61.26, 
52.62, 43.18, 38.34, 20.14, 19.57, 13.95, 13.72. HRMS (C19H23NO6Na+) calcd = 
384.141759 m/z, obsd = 384.141321 m/z. 
4b, (S)-diethyl 2-(2-(1, 3-dioxoisoindolin-2-yl)-4-methylpentyl)-2-methylmalonate: 
Reaction was set up and worked up according to the procedure reported 
for 4a. Materials used in this reaction are triflate 3b (6.64g, 17.5 mmol), diethyl 
methyl malonate (3.961 g, 22.75 mmol), sodium hydride (0.655g, 27.3 mmol) and 
anhydrous THF (60 mL). 3.10 g (7.68 mmol) of pure diester was recrystallized 
from cold diethyl ether as a clear crystalline solid in 44% yield. M.P. = 62-65 oC. 
[α]D23 = -38.8 (c = 1.0, CHCl3). IR (cm-1): 2956, 1770, 1705. 1H NMR (400 MHz, 
CDCl3) δ 7.95 – 7.61 (m, 4H), 4.48 (tdd, J = 10.5, 4.7, 3.0 Hz, 1H), 4.13 (qq, J = 
10.8, 7.1 Hz, 2H), 3.74 (ddq, J = 66.3, 10.8, 7.1 Hz, 2H), 2.97 (dd, J = 15.1, 10.5 
Hz, 1H), 2.25 – 2.09 (m, 2H), 1.48 (d, J = 6.6 Hz, 3H), 1.46 – 1.33 (m, 2H), 1.21 
(t, J = 7.1 Hz, 3H), 1.09 (t, J = 7.1 Hz, 3H), 0.89 (dd, J = 15.4, 6.3 Hz, 6H). 13C 
NMR (101 MHz, CDCl3) δ 172.19, 171.60, 168.33, 133.90, 132.17, 131.55, 
123.41, 122.72, 61.45, 61.22, 52.63, 45.85, 42.50, 37.54, 25.06, 23.11, 21.79, 
19.63, 13.96, 13.70. HRMS (C22H29NO6Na+) calcd = 426.188709 m/z, obsd = 
426.188385 m/z. 
4c, (S)-diethyl 2-(2-(1, 3-dioxoisoindolin-2-yl)-3-phenylpropyl)-2-methylmalonate: 
Reaction was set up and worked up according to the procedure reported for 4a. 
Crude product was purified by flash column chromatography (20% ethyl acetate / 
 59 
80% hexanes, Rf = 0.18). Pure product was analyzed by 1H NMR and the data 
matches to that of the product reported in literature.64 1H NMR (400 MHz, CDCl3) 
δ 7.84 – 7.54 (m, 4H), 7.21 – 7.02 (m, 5H), 4.73 – 4.57 (m, 1H), 4.22 – 4.00 (m, 
2H), 3.89 – 3.58 (m, 2H), 3.42 – 3.29 (m, 1H), 3.15 – 2.99 (m, 2H), 2.32 (dd, J = 
15.1, 2.9 Hz, 1H), 1.44 (d, J = 7.8 Hz, 3H), 1.23 – 1.18 (m, 3H), 1.09 (t, J = 7.1 
Hz, 3H). HRMS (C25H27NO6Na+) calcd = 460.173059 m/z, obsd = 460.172227 
m/z 
(2R, 4S)-5a, (2R, 4S)-4-(1,3-dioxoisoindolin-2-yl)-2-(ethoxycarbonyl)-2-
methylpentanoic acid: 
120 mg (0.332 mmol) of 4a, dissolved in 1.5 mL ethanol, was placed in a 
100 mL beaker containing 60 mL phosphate buffer of pH 7.4. Then, 0.120g (18 
units/mg) of crude Porcine Liver Esterase (PLE) enzyme was added to the above 
reaction beaker and the reaction was continued to stir vigorously. The pH of the 
reaction was maintained at 7.4 using an auto titrator that was set to deliver 1.0 M 
NaOH as the reaction progressed. After 16 hrs, the reaction went to completion. 
The pH of the reaction was brought up to 9.0 and a quick extraction was 
performed with ethyl acetate (1 x 30 mL). The aqueous portion was filtered 
through a celite bed under vacuum to remove the enzyme and then acidified to 
pH 2.0 using 12M HCl. The organics were extracted with diethyl ether (6 x 30 
mL). The resulting organic layers were combined and washed with brine (1 x 100 
mL), dried over MgSO4, filtered and solvent was removed under vacuum to 
provide 0.083g (0.249 mmol) of 5a in 75%yield and 78% de. IR (cm-1): 2983, 
1701. 1H NMR (400 MHz, CDCl3) δ 8.11 (dd, J = 85.0, 80.6 Hz, 1H), 7.83 – 7.64 
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(m, 4H), 4.53 (dqd, J = 10.3, 6.9, 3.4 Hz, 1H), 4.17 – 3.97 (m, 2H), 2.91 (dd, J = 
15.0, 9.9 Hz, 1H), 2.25 (dd, J = 15.0, 3.4 Hz, 1H), 1.50 (t, J = 5.6 Hz, 3H), 1.45 
(s, 3H), 1.22 (t, J = 7.1 Hz, 3H).  13C NMR (101 MHz, CDCl3) δ 176.41, 172.38, 
168.16, 134.01, 131.80, 123.21, 62.01, 52.55, 43.49, 38.98, 20.41, 20.09, 13.82. 
HRMS (C17H19NO6Na+) calcd = 356.110458 m/z, obsd = 356.109945 m/z. 
(2R, 4S)-5b, (2R, 4S)-4-(1, 3-dioxoisoindolin-2-yl)-2-(ethoxycarbonyl)-2, 6-
dimethylheptanoic acid: 
Reaction was set up according to the procedure reported for 5a. 0.3g 
(0.744 mmol) of 4b in 2.0 mL ethanol, 80 mL of phosphate buffer, 19mg of Crude 
PLE(18 units/mg) were used in this reaction. Reaction was stopped after 5 days 
and worked up. During the work up 60% of the unreacted starting material 4b, 
was recovered from the reaction. The work up procedure is similar to that 
reported for 5a, except for extractions were performed using dichloromethane 
instead of diethyl ether. After the work up 40 mg (0.106 mmol) of (2R, 4S)-5b 
was obtained as a clear liquid in 14% yield. The diastereomeric ratio was 
determined to be 6:1 from 1H NMR of the crude product. Flash column 
purification of the crude product did not improve the diastereomeric ratio as the 
mixture of diastereomers seemed to be inseparable. IR (cm-1): 2958, 1770, 
1704.1H NMR (400 MHz, CDCl3) δ 8.50 (s, 1H), 7.89 – 7.65 (m, 4H), 4.45 (ddd, J 
= 10.2, 6.9, 4.0 Hz, 1H), 4.21 – 4.02 (m, 2H), 2.85 (dd, J = 15.0, 10.1 Hz, 1H), 
2.24 – 2.12 (m, 2H), 2.02 (dd, J = 15.0, 2.6 Hz, 1H), 1.50 – 1.29 (m, 5H), 1.23 (t, 
J = 7.1 Hz, 3H), 0.92 (ddd, J = 19.0, 8.6, 4.5 Hz, 6H). 13C NMR (101 MHz, 
CDCl3) δ 176.57, 172.58, 168.37, 134.16, 123.58, 123.15, 62.15, 52.60, 46.24, 
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42.53, 38.32, 25.15, 23.21, 21.85, 20.59, 13.94. HRMS (C20H25NO6S Na+ ) calcd 
= 398.157409 m/z, obsd = 398.157033 m/z. 
(2R, 4S)-5c, (2R, 4S)-4-(1,3-dioxoisoindolin-2-yl)-2-(ethoxycarbonyl)-2-methyl-5-
phenylpentanoic acid: 
Reaction was set up according to the procedure reported for 5a. 2.38g 
(5.45 mmol) of 4c in 6.25 mL ethanol and 2.2 mL CH2Cl2 , 280 mL of phosphate 
buffer, 120 mg of Crude PLE(18 units/mg) were used in this reaction. Reaction 
was stopped after 7 days and worked up. The work up procedure is similar to 
that reported for 5a, except for extractions were performed using 
dichloromethane instead of diethyl ether. After the work up 1.442 g (3.52 mmol) 
of (2R, 4S)-5c was obtained as a clear hygroscopic liquid in 65% yield. The 
diastereomeric ratio was determined to be 4.1:1 from 1H NMR of the crude 
product. Flash column purification of the crude product did not improve the 
diastereomeric ratio, as the mixture of diastereomers seemed to be inseparable. 
IR (cm-1): 2983, 1772, 1704. 1H NMR (400 MHz, CDCl3) δ 7.85 – 7.51 (m, 4H), 
7.23 – 7.00 (m, 5H), 4.68 – 4.53 (m, 1H), 4.15 – 3.95 (m, 2H), 3.33 (dt, J = 9.2, 
8.1 Hz, 1H), 3.14 – 2.92 (m, 2H), 2.34 (dd, J = 15.0, 2.7 Hz, 1H), 1.45 – 1.40 (m, 
3H), 1.23 – 1.18 (m, 3H). HRMS (C23H23NO6 Na+) calcd = 432.141759 m/z, obsd 
= 432.141484 m/z. 
(2S, 4S)-6b, (S)-1-ethyl 3-(4-nitrobenzyl) 2-((S)-2-(1, 3-dioxoisoindolin-2-yl)-4-
methylpentyl)-2-methylmalonate: 
0.160g (0.426 mmol) of (2R, 4S)-5b (d.r = 6:1) was dissolved in 4 mL 
anhydrous DMF in a 100 mL, three neck flask at room temperature and under N2 
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atmosphere. 0.059g (0.426 mmol) of K2CO3 was added to the above flask and 
the contents were stirred for 10 minutes. Then, 0.092g (0.426 mmol) of 4-
nitrobenzyl bromide was added in a dropwise manner as a solution in 2 mL 
anhydrous DMF to the above reaction flask. Then the reaction mixture was 
allowed to stir overnight at room temperature and under N2 atmosphere. 6 mL 
water was added to the reaction flask and the organic contents were extracted 
with diethyl ether (4 x 6 mL). All organic portions were combined and washed 
with water (7 x 6 mL) followed by brine (3 x 6 mL). The organic portion was dried 
over MgSO4 and the solvent was removed under vacuum to provide crude 
product. Crude compound was purified by flash column chromatography (10% 
ethyl acetate / 90% hexanes) to provide 0.129 g (0.253 mmol) of pure (2S, 4S)-
6b in 59% Yield. (Rf = 0.38, 30% ethyl acetate / 70% hexanes) Our attempts to 
resolve diastereomers, to improve diastereomeric ratio, via flash column 
purification were not successful at this point. IR (cm-1): 2957, 1729, 1705. 1H 
NMR (400 MHz, CDCl3) δ 8.21 – 8.11 (m, 2H), 7.87 – 7.66 (m, 4H), 7.39 (dd, J = 
9.0, 2.1 Hz, 2H), 4.83 (dd, J = 74.9, 13.5 Hz, 2H), 4.58 – 4.42 (m, 1H), 4.07 (q, J 
= 7.1 Hz, 2H), 3.10 – 2.97 (m, 1H), 2.28 – 2.09 (m, 2H), 1.53 (d, J = 6.0 Hz, 3H), 
1.50 – 1.34 (m, 2H), 1.12 (t, J = 7.1 Hz, 3H), 0.89 (dt, J = 12.8, 6.4 Hz, 6H). 13C 
NMR (101 MHz, CDCl3) δ 171.72, 171.26, 168.39, 167.28, 147.69, 142.48, 
134.04, 128.23, 123.66, 65.40, 61.74, 52.86, 45.80, 42.52, 37.68, 25.04, 23.09, 
21.75, 19.70, 13.90. HRMS (C27H30N2O8 Na+) calcd = 533.189437 m/z, obsd = 
533.189437 m/z. 
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(2S, 4S)-6c, (S)-1-ethyl 3-(4-nitrobenzyl) 2-((S)-2-(1, 3-dioxoisoindolin-2-yl)-3-
phenylpropyl)-2-methylmalonate: 
1.506g (3.68 mmol) of (2R, 4S)-5c was dissolved in 25 mL anhydrous 
DMF in a 100 mL, three neck flask at room temperature and under N2 
atmosphere. 0.875g (4.05 mmol) of K2CO3 was added to the above flask and the 
contents were stirred for 10 minutes. Then, 0.560g (4.05 mmol) of 4-nitrobenzyl 
bromide was added in a dropwise manner as a solution in 5 mL anhydrous DMF 
to the above reaction flask. Then the reaction mixture was allowed to stir 
overnight at room temperature and under N2 atmosphere. After stirring for 18 hrs 
overnight, 40 mL water was added to the reaction flask and the organic contents 
were extracted with CH2Cl2 (4 x 50 mL). All organic portions were combined and 
washed with water (6 x 100 mL) followed by brine (1 x 150 mL). The organic 
portion was dried over MgSO4 and the solvent was removed under vacuum to 
provide crude product as viscous yellow liquid. Pure (2S, 4S)-6c was crystallized 
using ice cold diethyl ether in 67% yield. The diastereomeric ratio of the 
crystallized product was determined to be 24:1 from the 1H NMR data. M.P. = 
125 oC. [α]D24 = -118.1 (c = 1.0, CHCl3). IR (cm-1): 2940, 1726, 1707. 1H NMR 
(400 MHz, CDCl3) δ 8.21 – 8.12 (m, 2H), 7.78 – 7.54 (m, 4H), 7.38 (d, J = 8.8 Hz, 
2H), 7.21 – 7.03 (m, 5H), 4.92 (d, J = 13.4 Hz, 1H), 4.73 (d, J = 13.4 Hz, 1H), 
4.71 – 4.62 (m, 1H), 4.12 – 3.99 (m, 2H), 3.35 (dd, J = 13.7, 10.0 Hz, 1H), 3.19 – 
3.06 (m, 2H), 2.35 (dd, J = 15.1, 2.9 Hz, 1H), 1.49 (d, J = 6.5 Hz, 3H), 1.10 (t, J = 
7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 171.60, 171.16, 147.71, 142.42, 
137.31, 133.95, 128.94, 128.48, 128.24, 126.73, 123.68, 65.43, 61.78, 52.79, 
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49.06, 39.61, 36.82, 19.70, 13.88. HRMS (C30H28N2O8 Na+) calcd = 567.173787 
m/z, obsd = 567.173350 m/z. 
(3R, 5S)-7b, (3R, 5S)-ethyl 5-isobutyl-3-methyl-2-oxopyrrolidine-3-carboxylate: 
 
0.120g (0.242 mmol) of (2S, 4S)-6b  (d.r = 6:1) was dissolved in a solvent 
mixture of 4 mL methanol and 2 mL methylene chloride in a 25 mL single neck 
round bottom flask. 0.1 mL of hydrazine hydrate (35% in water) was added to the 
reaction flask and reaction mixture was heated to reflux the solvent. Reaction 
was monitored by TLC and also pH of the reaction was maintained between 8.0 
and 9.0 by using litmus paper After stirring for 24 hrs and additional 0.060 mL of 
hydrazine hydrate was added to the reaction to maintain the basic pH. Reaction 
was continued to stir for another 17 hrs (total reaction time of 41 hrs) and then 
cooled to room temperature. The white precipitate was washed with methylene 
chloride (5 x 6 mL) and the contents were filtered via a micro column to remove 
any white precipitate. The solvent was then removed under vacuum to provide 
crude material. The crude product was taken up in methylene chloride and the 
organic portion was washed with water (1 x 20 mL) followed by brine (1 x 20 mL). 
Organic portion was then dried over magnesium sulfate, filtered and the solvent 
was removed under vacuum. The resulted crude product was carefully purified 
via gradient flash column chromatography (45% ethyl acetate/55% hexanes to 
80% ethyl acetate/ 20% hexanes) to provide 14 mg (0.062 mmol) of 
diastereopure (3R, 5S)-7b in 26% yield. Rf = 0.11(80%EtOAc/20% Hexanes) The 
improvement in diastereopurity was confirmed from the 1H NMR data analysis. 
2D-NOESY experiment was performed on this diastereopure lactam and the 
 65 
stereochemistry at the quaternary chiral carbon was determined to be “R”. [α]D24 
= +6.1 (c = 0.3, CH2Cl2).IR (cm-1): 3218, 2957, 2872, 1737, 1701.1H NMR (400 
MHz, CDCl3) δ 6.26 (s, 1H), 4.28 – 4.14 (m, 2H), 3.69 (p, J = 7.0 Hz, 1H), 2.33 – 
2.24 (m, 1H), 2.13 (dd, J = 12.8, 7.0 Hz, 1H), 1.64 (tt, J = 13.1, 6.6 Hz, 1H), 1.58 
– 1.48 (m, 1H), 1.47 – 1.44 (m, 3H), 1.39 (ddd, J = 11.8, 7.3, 6.5 Hz, 1H), 1.32 – 
1.24 (m, 3H), 0.93 (dt, J = 6.7, 3.3 Hz, 6H). 13C NMR (101 MHz, CDCl3) δ 176.37, 
172.57, 61.56, 51.48, 49.60, 45.58, 40.27, 25.38, 22.82, 22.48, 20.26, 14.08. 
HRMS (C12H21NO3H+) calcd =228.159420 m/z, obsd = 228.159218 m/z. 
(3R, 5S)-7c, (3R, 5S)-ethyl 5-benzyl-3-methyl-2-oxopyrrolidine-3-carboxylate: 
0.310g (0.56 mmol) of (2S, 4S)-6c was dissolved in 8 mL methanol and 5 
mL CH2Cl2 and placed in a 50 mL single neck round bottom flask connected to a 
reflux condenser. Contents were stirred for 5 minutes and then 0.150 mL of 
hydrazine hydrate (35% w/v) was added to the reaction. After stirring for 10 
minutes at room temperature, the reaction mixture was heated to reflux the 
solvent for 5 days, at which time the reaction had gone to completion. Reaction 
was monitored by TLC. The pH of the reaction was maintained between 8.0 and 
9.0 by adding additional hydrazine hydrate (0.110 mL additional volume) over the 
course of reaction. Reaction was cooled to room temperature and a white fluffy 
solid precipitated out of the reaction mixture. The white solid was filtered off and 
the solvent was removed under vacuum to provide crude material. Crude 
material was then dissolved in 25 mL of CH2Cl2 and washed with water (1 x 20 
mL) followed by brine (1 x 20 mL). Organic portion was dried over MgSO4, 
filtered and solvent was removed under vacuum. The resulting material was 
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purified by gradient column chromatography (20% ethyl acetate/80% hexanes to 
80% ethyl acetate/20% hexanes) to provide 0.103 g (0.394 mmol) of pure (3R, 
5S)-7c as light yellowish crystalline solid in 70% yield. Rf = 0.18 (80% ethyl 
acetate/20% hexanes), M.P. = 78-80 oC. [α]D25 = -29.4 (c = 1.0, CHCl3). IR (cm-1): 
3202, 3087, 2986, 2939, 1729, 1688. 1H NMR (400 MHz, CDCl3) δ 7.33 (ddd, J = 
7.5, 4.4, 1.3 Hz, 2H), 7.29 – 7.23 (m, 1H), 7.22 – 7.16 (m, 2H), 5.81 (s, 1H), 4.29 
– 4.20 (m, 2H), 3.89 – 3.78 (m, 1H), 2.86 (ddd, J = 21.8, 13.4, 7.1 Hz, 2H), 2.46 
(dd, J = 13.2, 6.4 Hz, 1H), 2.14 (dd, J = 13.2, 7.4 Hz, 1H), 1.45 (d, J = 2.9 Hz, 
3H), 1.32 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 175.84, 172.45, 
137.45, 128.97, 128.92, 127.01, 61.71, 52.87, 51.49, 42.78, 39.40, 20.52, 14.13. 
HRMS (C15H19NO3 Na+) calcd = 284.125715 m/z, obsd = 284.125416 m/z. 
(3S, 5S)-8c, (3S, 5S)-ethyl 5-benzyl-3-methyl-2-thioxopyrrolidine-3-carboxylate: 
0.906g (3.46 mmol) of (3R, 5S)-7c was placed in a 100 mL single neck 
round bottom flask and dissolved in 20 mL of freshly distilled toluene. Then 
0.716g (1.77 mmol) of Lawesson’s reagent was added to the above flask and the 
reaction mixture was heated to 105 oC for 2 hrs under N2 atmosphere using oil 
bath set up. Reaction mixture was cooled to room temperature and solvent was 
removed under vacuum. Diethyl ether (25 mL) was added to the above crude 
material and the organics were washed with water (2 x 15 mL) followed by brine 
(1 x 20 mL). Ether portion was dried over MgSO4, filtered and solvent was 
removed under vacuum to afford crude product as viscous yellow liquid. 
Purification by gradient flash column chromatography (25% ethyl acetate/75% 
hexanes, Rf = 0.36) yielded 0.830g (2.996 mmol) of pure (3S, 5S)-8c as a clear 
 67 
viscous liquid in 87% yield.  [α]D22 = -114.3 (c = 1.0, CHCl3). IR (cm-1): 3155, 
2979, 2932, 1732. 1H NMR (400 MHz, CDCl3) δ 8.39 (s, 1H), 7.42 – 7.13 (m, 
5H), 4.24 (q, J = 7.1 Hz, 2H), 4.13 (p, J = 7.3 Hz, 1H), 3.05 – 2.90 (m, 2H), 2.54 
(dd, J = 13.0, 7.3 Hz, 1H), 2.21 (dd, J = 13.0, 7.4 Hz, 1H), 1.51 (s, 3H), 1.31 (t, J 
= 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 206.08, 171.97, 136.69, 129.01, 
128.96, 127.18, 61.83, 61.42, 60.90, 41.32, 40.64, 23.25, 14.05. HRMS 
(C15H19NO2S Na+) calcd =300.102871 m/z, obsd = 300.103024 m/z. 
(3R, 5S)-9c, (3R, 5S)-ethyl 5-benzyl-3-methylpyrrolidine-3-carboxylate: 
To a 50 mL three neck flask, 2.5 mL Raney Nickel slurry in water was 
added. Raney Nickel was washed with water (3 x 5 mL), methanol (3 x 5 mL) and 
THF (3 x 5 mL) in the same order. 6 mL THF was added to the above flask and 
hydrogen gas bubbled through the reaction for 30 minutes. Then 0.102g (0.368 
mmol) of (3S, 5S)-8c was added as solution in 2mL THF and the reaction was 
allowed to stir, under H2 atmosphere for 24 hrs at which time it went to 
completion. Raney-Ni was filtered off on the celite bed and solvent was removed 
under vacuum. Crude material was then purified by gradient flash column 
chromatography using 40% hexanes/60%ethyl acetate to 100% ethyl Acetate, Rf 
= 0.16 (40% hexanes/60% ethyl acetate treated with NH4OH) (Solvent was 
treated with 30% NH4OH in water and decanted prior to use. 150 mL of NH4OH 
mixed with 500 mL of 40% hexanes / 60% ethyl acetate) to afford 0.048g (0.194 
mmol) of pure (3R, 5S)-9c as light yellow liquid in 53% yield. [α]D22 = +60.1 (c = 
1.0, CHCl3). IR (cm-1): 3027, 2975, 2933, 2872, 1721. 1H NMR (400 MHz, CDCl3) 
δ 7.33 – 7.16 (m, 5H), 4.18 – 4.08 (m, 2H), 3.45 (d, J = 11.6 Hz, 1H), 3.42 – 3.32 
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(m, 1H), 2.88 (dd, J = 13.4, 6.6 Hz, 1H), 2.74 (dt, J = 13.4, 4.9 Hz, 1H), 2.62 (d, J 
= 11.6 Hz, 1H), 2.03 – 1.88 (m, 2H), 1.71 (dd, J = 12.9, 6.8 Hz, 1H), 1.29 – 1.20 
(m, 6H). 13C NMR (101 MHz, CDCl3) δ 177.79, 139.50, 129.00, 128.41, 126.21, 
60.91, 60.68, 58.48, 49.93, 44.21, 41.71, 23.67, 14.19. HRMS (C15H21NO2 H+) 
calcd = 248.164505 m/z, obsd = 248.164259 m/z. 
(3R, 5S)-10c, (3R, 5S)-5-benzyl-3-methylpyrrolidine-3-carboxylic acid: 
To a one neck 100 mL round bottom flask containing 0.130g (0.53 mmol) of (3R, 
5S)-9c, 24 mL of 6.0 N HCl was added and the solvent was heated to reflux. 
Reaction went to completion after refluxing for 24 hrs. At this point reaction 
mixture was cooled and solvent was removed under high vacuum to afford 
0.136g (0.53 mmol) of (3R, 5S)-10c hydrochloride salt as white solid in 
quantitative yield. The crude product was then loaded onto DOWEX 50X8-200 
resin, to remove chloride salts, and the product was eluted using 15% NH4OH.in 
water. Fractions were collected and solvent was removed under high vacuum to 
provide (3R, 5S)-10c in its zwitterionic form as light brown hygroscopic solid. 
M.P. (HCl salt) = 175-176 oC. [α]D23 (HCl salt) = -16.8 (c = 1.0, MeOH). IR (cm-1): 
2937, 1732. 1H NMR (400 MHz, MeOD) δ 7.32 – 7.17 (m, 5H), 3.62 – 3.44 (m, 
2H), 2.96 (dd, J = 13.4, 6.7 Hz, 1H), 2.82 (dt, J = 13.4, 6.7 Hz, 1H), 2.64 (t, J = 
11.0 Hz, 1H), 2.07 (dd, J = 13.0, 8.9 Hz, 1H), 1.74 (dt, J = 13.9, 7.0 Hz, 1H), 1.26 
(s, 3H). 13C NMR (101 MHz, MeOD) δ 184.89, 140.04, 130.19, 129.77, 127.72, 
62.24, 57.97, 52.06, 44.93, 41.69, 25.05. HRMS (C13H17NO2Na+) calcd = 
242.115150 m/z, obsd = 242.114982 m/z. 
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(2S, 4S)-5c, (2S, 4S)-4-(1, 3-dioxoisoindolin-2-yl)-2-(ethoxycarbonyl)-2-methyl-5-
phenylpentanoic acid: 
This reaction was performed using PLE isoenzyme 3 (250 units/mmol 
diester). Reaction was set up and worked up according to the procedure reported 
for (2R, 4S)-5c. Reaction yielded the product half ester (2S, 4S)-5c in 30% yield 
and up to 50% of the unreacted starting material was recovered during the work 
up. 1H NMR was obtained on the crude product and the diastereomeric ratio was 
determined to be 4:1. IR (cm-1): 2985, 1772, 1708. 1H NMR (400 MHz, CDCl3) δ 
9.04 (s, 1H), 7.82 – 7.58 (m, 5H), 7.20 – 7.11 (m, 5H), 4.71 – 4.59 (m, 1H), 3.90 
– 3.61 (m, 2H), 3.40 – 3.31 (m, 1H), 3.10 (ddd, J = 13.7, 8.4, 2.3 Hz, 2H), 2.25 
(dd, J = 15.0, 2.5 Hz, 1H), 1.47 (s, 3H), 1.10 (t, J = 7.1 Hz, 3H). 13C NMR (101 
MHz, CDCl3) δ 176.94, 171.50, 168.49, 137.40, 133.94, 131.57, 128.94, 128.45, 
126.68, 123.14, 61.77, 52.40, 50.44, 49.04, 45.90, 39.49, 36.74, 20.00, 13.83, 
13.58. HRMS (C23H23NO6Na+) calcd = 432.141759 m/z, obsd = 432.141203 m/z. 
(2R, 4S)-6c, (R)-1-ethyl 3-(4-nitrobenzyl) 2-((S)-2-(1, 3-dioxoisoindolin-2-yl)-3-
phenylpropyl) - 2-methylmalonate: 
Reaction was set up and worked up according to the procedure reported 
for (2S, 4S)-6c. Materials used in this reaction are; Half ester (2S, 4S)-5c 
(1.146g, 2.8 mmol), 4-nitrobenzylbromide (0.605g, 2.8 mmol), potassium 
carbonate (0.387g, 2.8 mmol) and anhydrous DMF (30 mL). This reaction 
provided 1.40g (2.56 mmol) of the 4-nitrobenzylester (d.r = 4:1) in 91% yield. 1H 
NMR of the crude product was obtained and the data suggested that the product 
was essentially pure. Hence it was taken to the next step without any further 
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purification. IR (cm-1): 2982, 1728, 1706. 1H NMR (400 MHz, CDCl3) δ 8.19 (d, J 
= 8.8 Hz, 2H), 7.79 – 7.60 (m, 4H), 7.45 (d, J = 8.7 Hz, 2H), 7.19 – 7.06 (m, 5H), 
5.25 – 5.13 (m, 2H), 4.95 – 4.72 (m, 1H), 4.71 – 4.61 (m, 1H), 4.10 – 4.02 (m, 
1H), 3.85 – 3.64 (m, 2H), 3.35 (dt, J = 13.7, 9.2 Hz, 1H), 3.16 – 3.05 (m, 2H), 
2.36 (dt, J = 15.0, 2.8 Hz, 1H), 1.53 – 1.45 (m, 3H), 1.11 (t, J = 7.1 Hz, 1H), 1.03 
(t, J = 7.1 Hz, 2H). 13C NMR (101 MHz, CDCl3) δ 171.60, 171.11, 167.71, 147.73, 
142.65, 137.35, 133.95, 128.93, 128.45, 128.27, 128.24, 126.70, 123.76, 123.66, 
65.56, 61.60, 52.77, 49.05, 39.55, 36.79, 19.75, 13.66. HRMS (C30H28N2O8Na+) 
calcd = 567.173787 m/z, obsd = 567.173239 m/z. 
(3S, 5S)-7c, (3S, 5S)-ethyl 5-benzyl-3-methyl-2-oxopyrrolidine-3-carboxylate: 
The title compound (3S, 5S)-7c was prepared from two different 
compounds for our synthetic purposes. In the method 1, the 4-nitro benzylic ester 
(2R, 4S)-6c was used in a stereoselective cyclization procedure. In the method 2 
the malonate diester 4c was treated with hydrazine hydrate in a non-selective 
cyclization methodology. 
Method 1 [From (2R, 4S)-6c]: Reaction was set up and worked up according to 
the procedure reported for (3R, 5S)-7c. The reaction was refluxed for 2 days and 
then worked up. Materials used in this reaction are (2R, 4S)-6c (1.273g, 2.47 
mmol), N2H4.H2O (1.14 mL), methanol (12 mL) and methylene chloride (8 mL). 
Crude product was purified carefully by flash column chromatography (40% ethyl 
acetate/60% hexanes, Rf = 0.3) to cause the separation of diastereomers and 
provide 0.200g (0.766 mmol) of diastereopure (3S, 5S)-7c in 31% yield.  
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Method 2 (From 4c): 1.775 g (4.05 mmol) of diester 4c was dissolved in 
15 mL methanol and 15 mL methylene chloride mixture in a 100 mL single neck 
round bottom flask. To this flask was added 1.48 mL of hydrazine monohydrate 
(35% in water) and the reaction mixture was heated to reflux the solvent. 
Reaction was monitored by TLC and it went to completion after 5 days. 
Additional 0.6 mL of hydrazine hydrate was added after refluxing for 4 days to 
maintain the pH between 8.0 and 9.0. Reaction mixture was cooled to room 
temperature, filtered under vacuum and the solvent was removed on the 
rotovapor. To the resulting organic portion, 30 mL methylene chloride was added 
and the contents were filtered again to remove any remaining white solid. The 
white solid was washed methylene chloride (3 x 20 mL) to retrieve any organic 
material. All the methylene chloride portions were combined and the solvent was 
removed under vacuum to provide crude product, a mixture of diastereomers of 
7C, as viscous light yellow liquid. The crude material was then purified carefully 
by flash column chromatography (40% ethyl acetate/ 60% hexanes, Rf = 0.3) to 
provide the 0.300g (1.15 mmol) of diastereopure (3S, 5S)-7c in 29% yield. M.P = 
87-89 oC. [α]D23 = -47.6 (c = 1.0, CH2Cl2). IR (cm-1): 3206, 2960, 2936, 2881, 
1704, 1675.1H NMR (400 MHz, CDCl3) δ 7.40 – 7.10 (m, 5H), 5.77 (s, 1H), 4.17 
(q, J = 7.1 Hz, 2H), 3.99 (tt, J = 8.4, 6.6 Hz, 1H), 2.90 (dd, J = 13.5, 5.3 Hz, 1H), 
2.69 (ddd, J = 19.5, 13.3, 7.6 Hz, 2H), 1.70 (dt, J = 15.4, 7.7 Hz, 1H), 1.46 (s, 
3H), 1.25 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 175.20, 172.12, 
137.26, 128.93, 128.90, 127.07, 61.64, 53.14, 51.92, 43.13, 40.88, 21.03, 14.08. 
HRMS (C15H19NO3H+) calcd = 262.143770 m/z, obsd = 262.143493 m/z. 
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(3R, 5S)-8c, (3R, 5S)-ethyl 5-benzyl-3-methyl-2-thioxopyrrolidine-3-carboxylate: 
0.171g (0.654 mmol) of (3S, 5S)-7c was dissolved in 8 mL of freshly 
distilled toluene in a single neck 25 mL round bottom flask with a stir bar. To the 
flask, 0.133 g (0.327 mmol) of Lawesson’s reagent was added and the reaction 
mixture was heated to 95 oC for 1.5 hrs under N2 atmosphere at which time the 
reaction went to completion. Reaction mixture was then cooled to room 
temperature and solvent was removed under vacuum. Diethyl ether (15 mL) was 
added to the above crude material and the organics were washed with water (2 x 
10mL) followed by brine (1 x 15 mL). Ether portion was dried over MgSO4, 
filtered and solvent was removed under vacuum. Flash column chromatography 
(30% ethyl acetate / 70% hexanes, Rf = 0.38) of the crude material yielded 
0.180g (0.649mmol) of pure (3R, 5S)-8c in 99% yield as a white solid. M.P. = 
129-131 oC. [α]D23 = -72.4 (c = 1.0, CH2Cl2). IR (cm-1): 3350, 2985, 2931, 1722. 
1H NMR (400 MHz, CDCl3) δ 7.90 (s, 1H), 7.40 – 7.31 (m, 2H), 7.31 – 7.27 (m, 
1H), 7.23 – 7.17 (m, 2H), 4.36 – 4.25 (m, 1H), 4.20 – 4.13 (m, 2H), 2.95 (dd, J = 
13.7, 5.6 Hz, 1H), 2.77 (dt, J = 13.7, 7.8 Hz, 2H), 1.79 (dd, J = 13.2, 8.6 Hz, 1H), 
1.57 (s, 3H), 1.25 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 205.54, 
171.69, 136.74, 129.23, 128.98, 127.43, 61.91, 61.08, 60.75, 42.19, 41.98, 
24.13, 14.12. HRMS (C15H19NO2S Na+) calcd = 300.102871 m/z, obsd = 
300.102969 m/z. 
(3S, 5S)-9c, (3R, 5S)-ethyl 5-benzyl-3-methylpyrrolidine-3-carboxylate: 
To a 25 mL three neck flask, 2.0 mL of Raney Nickel slurry in water was 
added. Raney Nickel was washed with water (2 x 5 mL), methanol (2 x 5 mL) and 
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THF (2 x 5 mL) in the same order. 4 mL THF was added to the above flask and 
the hydrogen gas was bubbled through the solution for 30 minutes. Then 0.160g 
(0.577 mmol) of (3R, 5S)-8c was added to the above flask, as a solution in 3 mL 
THF and 1mL ethanol. The reaction contents were allowed to stir, under H2 
atmosphere, for 6 hrs at which time the reaction went to completion. Raney-Ni 
was filtered off on the celite bed and solvent was removed under vacuum to 
provide crude material as light greenish yellow liquid. Crude material was then 
purified by gradient flash column chromatography, using 40% ethyl acetate/60% 
hexanes to 100% ethyl acetate (Solvent was treated with NH4OH and then 
decanted prior to use as reported for (3R, 5S)-9c) to afford 0.084g (0.340 mmol) 
of pure (3S, 5S)-9c as light yellow liquid in 59% yield. Rf = 0.38 (40% ethyl 
acetate/60% hexanes treated with NH4OH) [α]D23 = -9.8 (c = 1.0, CHCl3). IR (cm-
1): 3026, 2974, 2930, 2872, 1721.  1H NMR (400 MHz, CDCl3) δ 7.32 – 7.25 (m, 
2H), 7.19 (dd, J = 10.0, 4.2 Hz, 3H), 4.12 (q, J = 7.1 Hz, 2H), 3.44 (dq, J = 13.9, 
6.9 Hz, 1H), 3.27 (d, J = 11.1 Hz, 1H), 2.84 – 2.69 (m, 3H), 2.41 (dd, J = 13.0, 
6.9 Hz, 1H), 2.05 – 1.92 (m, 1H), 1.31 (d, J = 2.3 Hz, 3H), 1.30 – 1.26 (m, 1H), 
1.23 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 177.34, 139.66, 129.02, 
128.40, 126.17, 60.88, 60.64, 57.38, 50.10, 44.14, 42.57, 24.51, 14.17. HRMS 
(C15H21NO2 H+) calcd = 248.164505 m/z, obsd = 248.164453 m/z. 
(3S, 5S)-10c, (3S, 5S)-5-benzyl-3-methylpyrrolidine-3-carboxylic acid: 
To a one neck 25 mL round bottom flask containing 0.062g (0.25 mmol) of 
(3S, 5S)-9c, 6 mL of 6.0 N HCl was added and the solvent was heated to reflux. 
Reaction went to completion after refluxing for 24 hrs. At this point reaction 
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mixture was cooled and solvent was removed under high vacuum to afford 
0.063g (0.247 mmol) of (3R, 5S)-10c hydrochloride salt as white solid in 99 % 
yield. The crude product was then loaded onto DOWEX 50X8-200 resin, to 
remove chloride salts, and the product was eluted using 15% NH4OH. Fractions 
were collected and solvent was removed under high vacuum to provide (3S, 5S)-
10c in its zwitterionic form as white solid. M.P. = 207-209 oC. [α]D23 (HCl Salt) = -
9.1 (c = 1.0, MeOH). IR (cm-1):2967, 2930, 1628. 1H NMR (400 MHz, D2O) δ 7.44 
– 7.30 (m, 5H), 3.88 – 3.77 (m, 1H), 3.67 (d, J = 11.8 Hz, 1H), 3.14 – 2.93 (m, 
3H), 2.54 (dd, J = 13.4, 6.4 Hz, 1H), 1.66 (dd, J = 13.4, 11.3 Hz, 1H), 1.33 (s, 
3H). 13C NMR (101 MHz, D2O) δ 182.89, 136.89, 128.99, 128.90, 127.23, 61.47, 
54.11, 50.46, 42.11, 37.93, 23.37. HRMS (C13H17NO2H+) calcd = 220.133205 
m/z, obsd = 220.132985 m/z. 
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2.5 X-ray Crystal Data 
2.5.1 Crystal data for (2S, 4S)-6c 
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Table 1. Crystal data and structure refinement for (2S, 4S)-6c. 
 
Empirical formula  C30 H28 N2 O8 
Formula weight  544.54 
Crystal system  orthorhombic 
Space group  P212121 
Unit cell dimensions  a = 8.5572(3) Å = 90° 
 b = 14.4690(6) Å = 90° 
 c = 21.6842(9) Å = 90° 
Volume 2684.81(18) Å3 
Z, Z' 4, 1 
Density (calculated) 1.347 Mg/m3 
Wavelength  0.71073 Å 
Temperature  100(2) K 
F(000) 1144 
Absorption coefficient 0.099 mm-1 
Absorption correction semi-empirical from equivalents 
Max. and min. transmission 0.985 and 0.951 
Theta range for data collection 1.692 to 31.491° 
Reflections collected 56452 
Independent reflections 8545 [R(int) = 0.0264] 
Data / restraints / parameters 8545 / 0 / 361 
wR(F2 all data) wR2 = 0.0855 
R(F obsd data) R1 = 0.0313 
Goodness-of-fit on F2 1.007 
Observed data [I > 2(I)] 8025 
Absolute structure parameter -0.20(14) 
Largest and mean shift / s.u. 0.001and 0.000 
Largest diff. peak and hole 0.322 and -0.198 e/Å3  
----------  
wR2 = {  [w(Fo
2 - Fc
2)2] /  [w(Fo 
2)2] }1/2  
R1 =  ||Fo| - |Fc|| /  |Fo| 
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 Table 2.  Atomic coordinates and equivalent isotropic displacement parameters 
for (2S, 4S)-6c. U(eq) is defined as one third of the trace of the orthogonalized Uij 
tensor. 
______________________________________________________________    
 x y z U(eq) 
______________________________________________________________  
 
O(1) 0.05256(11) 0.68625(7) 0.29464(5) 0.01800(18) 
O(2) 0.06156(13) 0.54059(7) 0.25815(5) 0.0242(2) 
O(3) 0.18883(11) 0.60108(6) 0.41163(4) 0.01694(18) 
O(4) 0.35721(13) 0.71601(7) 0.38871(5) 0.0214(2) 
O(5) -0.15944(14) 0.45655(9) 0.70153(5) 0.0286(2) 
O(6) -0.16755(16) 0.33918(9) 0.63925(6) 0.0331(3) 
O(7) 0.71303(12) 0.61550(7) 0.39900(5) 0.0221(2) 
O(8) 0.33864(12) 0.39580(7) 0.43856(4) 0.01902(19) 
N(1) -0.13188(14) 0.41934(9) 0.65163(6) 0.0223(2) 
N(2) 0.51814(13) 0.50334(7) 0.40228(5) 0.01403(19) 
C(1) -0.16795(18) 0.78698(11) 0.28948(8) 0.0263(3) 
C(2) -0.10613(16) 0.69421(10) 0.26965(7) 0.0202(3) 
C(3) 0.12128(15) 0.60459(9) 0.28468(6) 0.0164(2) 
C(4) 0.28971(15) 0.60474(9) 0.30936(6) 0.0145(2) 
C(5) 0.38737(17) 0.66605(10) 0.26627(7) 0.0210(3) 
C(6) 0.28602(14) 0.64799(9) 0.37351(6) 0.0150(2) 
C(7) 0.16346(18) 0.64599(10) 0.47021(6) 0.0209(3) 
C(8) 0.08871(15) 0.58159(9) 0.51545(6) 0.0166(2) 
C(9) 0.07890(15) 0.61329(10) 0.57641(6) 0.0188(2) 
C(10) 0.00842(16) 0.55994(10) 0.62127(6) 0.0202(3) 
C(11) -0.05060(16) 0.47424(10) 0.60450(6) 0.0185(2) 
C(12) -0.04168(17) 0.44050(9) 0.54475(6) 0.0195(2) 
C(13) 0.02851(16) 0.49537(9) 0.49984(6) 0.0185(2) 
C(14) 0.34574(16) 0.50332(9) 0.31027(6) 0.0159(2) 
C(15) 0.50913(15) 0.48395(9) 0.33596(6) 0.0153(2) 
C(16) 0.55235(17) 0.38240(9) 0.32162(6) 0.0182(2) 
C(17) 0.69616(16) 0.34764(9) 0.35442(6) 0.0169(2) 
C(18) 0.68179(17) 0.29080(9) 0.40625(7) 0.0203(3) 
C(19) 0.8136(2) 0.25819(10) 0.43716(7) 0.0256(3) 
C(20) 0.96157(19) 0.28115(11) 0.41606(8) 0.0279(3) 
C(21) 0.97757(18) 0.33765(12) 0.36465(8) 0.0283(3) 
C(22) 0.84587(18) 0.37128(10) 0.33422(7) 0.0225(3) 
C(23) 0.62382(15) 0.56728(8) 0.42789(6) 0.0151(2) 
C(24) 0.66877(16) 0.61298(9) 0.54269(6) 0.0180(2) 
C(25) 0.61825(17) 0.59519(10) 0.60294(6) 0.0216(3) 
C(26) 0.50375(18) 0.52905(10) 0.61510(6) 0.0220(3) 
C(27) 0.43416(17) 0.47853(9) 0.56747(6) 0.0194(2) 
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C(28) 0.43286(15) 0.45659(8) 0.44794(6) 0.0147(2) 
C(29) 0.59807(15) 0.56311(9) 0.49590(6) 0.0150(2) 
C(30) 0.48348(15) 0.49743(9) 0.50790(6) 0.0153(2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 79 
2.5.2 Crystal data for (3S, 5S)-7c 
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Table 1.  Crystal data and structure refinement for (3S, 5S)-7c. 
 
Empirical formula  C15 H19 N O3 
Formula weight  261.31 
Crystal system  orthorhombic 
Space group  P212121 
Unit cell dimensions  a = 8.2960(4) Å = 90° 
 b = 12.0188(6) Å = 90° 
 c = 13.9373(7) Å = 90° 
Volume 1389.66(12) Å3 
Z, Z' 4 
Density (calculated) 1.249 Mg/m3 
Wavelength  0.71073 Å 
Temperature  100(2) K 
F(000) 560 
Absorption coefficient 0.087 mm-1 
Absorption correction semi-empirical from equivalents 
Max. and min. transmission 0.976 and 0.974 
Theta range for data collection 2.238 to 27.509° 
Reflections collected 26670 
Independent reflections 3177 [R(int) = 0.0203] 
Data / restraints / parameters 3177 / 0 / 178 
wR(F2 all data) wR2 = 0.0833 
R(F obsd data) R1 = 0.0291 
Goodness-of-fit on F2 1.011 
Observed data [I > 2(I)] 3096 
Absolute structure parameter 0.1(10) 
Largest and mean shift / s.u. 0.000 and 0.000 
Largest diff. peak and hole 0.221 and -0.145 e/Å3  
----------  
wR2 = {  [w(Fo
2 - Fc
2)2] /  [w(Fo 
2)2] }1/2  
R1 =  ||Fo| - |Fc|| /  |Fo| 
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 Table 2.  Atomic coordinates and equivalent isotropic displacement parameters 
for (3S, 5S)-7c. U(eq) is defined as one third of the trace of the orthogonalized Uij 
tensor. 
______________________________________________________________    
 x y z U(eq) 
______________________________________________________________  
 
N(1) 0.59811(15) 0.29071(10) 0.89917(8) 0.0175(2) 
C(2) 0.44162(17) 0.27271(12) 0.91687(10) 0.0170(3) 
C(3) 0.34493(16) 0.29534(11) 0.82406(9) 0.0160(3) 
C(4) 0.47801(16) 0.30590(13) 0.74759(10) 0.0186(3) 
C(5) 0.63538(16) 0.33023(11) 0.80234(9) 0.0157(3) 
O(6) 0.38237(13) 0.24390(11) 0.99377(8) 0.0246(2) 
C(7) 0.22567(18) 0.20064(12) 0.80541(11) 0.0215(3) 
C(8) 0.26215(16) 0.40745(12) 0.84158(9) 0.0170(3) 
O(9) 0.32363(14) 0.49615(9) 0.82484(9) 0.0262(3) 
O(10) 0.11725(13) 0.39326(9) 0.88102(8) 0.0210(2) 
C(11) 0.03098(18) 0.49158(13) 0.91395(11) 0.0226(3) 
C(12) 0.0730(2) 0.51660(13) 1.01722(12) 0.0258(3) 
C(13) 0.78423(16) 0.27207(12) 0.76111(10) 0.0169(3) 
C(14) 0.82440(16) 0.31608(12) 0.66225(10) 0.0169(3) 
C(15) 0.76694(18) 0.26287(13) 0.58038(10) 0.0203(3) 
C(16) 0.7980(2) 0.30584(14) 0.48910(11) 0.0252(3) 
C(17) 0.8884(2) 0.40235(14) 0.47883(11) 0.0271(3) 
C(18) 0.9468(2) 0.45630(14) 0.55996(12) 0.0269(3) 
C(19) 0.91537(18) 0.41336(12) 0.65107(11) 0.0221(3) 
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CHAPTER III - CATALYTIC EVALUATION OF DESIGNED 5-BENZYL-3-
METHYLPYRROLIDINE-3-CARBOXYLIC ACID IN ALDOL AND MANNICH 
REACTIONS 
3.1 Hypothesis 2:  
The designed 5-benzyl-Cα-methyl-β-proline analogue will be an efficient 
organocatalyst in asymmetric anti-Mannich reactions and also in Aldol reactions. 
3.2 Background 
Aldol and Mannich reactions are both very important reactions in the field 
of organic chemistry as they involve the carbon-carbon bond formation under 
mild reaction conditions. Aldol reaction occurs between two carbonyl compounds 
whereas the Mannich reaction is between amines and carbonyl compounds. Both 
Aldol and Mannich reactions are very well known to be catalyzed by L-proline. 
3.2.1 Mannich Reaction 
In organic chemistry, the Mannich reaction is an important carbon-carbon 
bond forming reaction primarily between carbonyl compounds and amines. 
However, a modified Mannich reaction is utilized in Eschenmoser methenylation 
reaction for the synthesis of α-methenylated carbonyl compounds.97-99 In 
Mannich reaction, an activated carbonyl compound (aldehyde or ketone) is 
condensed with an amine (usually primary or secondary) and an enolizable 
carbonyl compound (aldehyde or ketone) to form amino alkylated products. In 
Mannich reactions catalyzed by metal catalysts or other organocatalysts 
(including L-Proline), products formed are syn selective.7,21,100 For the first time, 
List reported a Mannich reaction catalyzed by L-Proline that yielded syn selective 
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Mannich product.22  β-Proline and its analogues catalyze the asymmetric 
Mannich reaction to provide anti selective Mannich products.57,61,101 Barbas et al 
reported anti selective asymmetric Mannich reaction with a designed β-proline 
analogue as catalyst.56  
(R)-Cα-Methyl-β-proline designed by our group was tested for its catalytic 
activity in the Mannich reaction by Dr. Banerjee. However these results were not 
published by our group. The Mannich reaction was performed using 
isovaleraldehyde and p-methoxy phenyl (PMP) protected imine (Scheme 16). 
(R)-Cα-Methyl-β-proline showed good “anti” selectivity with a diastereomeric ratio 
of 8:1 (anti: syn) and an enantiomeric excess of 97%. The catalyst loading for the 
asymmetric Mannich reaction was 5% and the reaction time was 4 hrs. The 
reaction was performed in DMSO and the overall yield of the reaction was found 
to be 75%. These results suggested that (R)-Cα-methyl-β-proline is an efficient 
catalyst in the asymmetric Mannich reaction with good “anti” selectivity. The 
catalytic activity of (R)-Cα-methyl-β-proline was also independently verified by 
Nagata and coworkers and their data supports our results. However our synthetic 
strategy for (R)-α-methyl-β-proline is far superior to the strategy reported by 
Nagata et al.102  With the preliminary data supporting the efficiency of Cα-methyl-
β-proline as a catalyst in the asymmetric Mannich reaction, we want to expand 
the scope of β-proline analogues as catalysts not only to the Mannich reaction 
but also to the Aldol reaction. We hypothesized that:  
(i) Substituents on the pyrrolidine ring could improve the hydrophobic 
character of the catalyst that will facilitate organic reactions in relatively 
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non-polar organic solvents. This would provide expanded solvent choice 
for the organocatalytic reactions which in turn expands the substrate 
scope.   
(ii) Cα-Methyl-β-proline analogue will catalyze asymmetric Mannich reactions 
in non-polar organic solvents with good anti stereoselectivities.  
(iii) The steric hindrance caused by the benzyl substituent at position 5 on 
the pyrrolidine ring will be responsible for the formation of stereoselective 
products in the Aldol reaction as the Aldol reaction does not involve a 
strong hydrogen bond acceptor like an Imine in the Mannich reaction.   
3.2.2 Aldol reaction 
The designed β-proline analogue was tested for its activity in the Aldol 
reaction between acetone and 4-nitro benzaldehyde as shown in Scheme 3.1. 
The reaction shown in Scheme 3.1 was the first intermolecular aldol addition 
reaction reported to be catalyzed by L-proline. We chose this reaction to test the 
catalytic activity of our designed β-proline analogue as this has been the gold 
standard reaction in the field of enamine catalysis by L-proline since it was first 
reported by List et al. 
 
Scheme 3.1 Aldol reaction between acetone and 4-nitrobenzaldehyde 
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In direct aldol reactions proline and its derivatives follow enamine 
mechanism to provide enantioselective products.103-105 Based on the mechanism 
of enamine catalysis by proline analogues, we proposed a transition state model 
(Figure 3.1) for the asymmetric Aldol reaction catalyzed by (3S, 5S)-5-benzyl-3-
methylpyrrolidine-3-carboxylic acid, (3S, 5S)-10c. In the transition state (Figure 
3) of the Aldol reaction (Scheme 3.1), we hypothesized the enamine’s 
nucleophilic attack on 4-nitro benzaldehyde is from the “re” face (Figure 3.1).  
 
Figure 3.1 Predicted transition state model for the Aldol reaction catalyzed by 
(3S, 5S)-5-benzyl-3-methylpyrrolidine-3-carboxylic acid, (3S, 5S)-10c 
After examining the transition state model, we proposed two reasons for 
the “re” facial attack of the enamine on 4-nitrobenzaldehyde.  
(i) In the transition state, the enamine is aligned in such a way that it is 
away from the benzylic substituent at position 5 on the pyrrolidine ring 
as shown in Figure 3.1. 
(ii) The bulky benzyl group on pyrrolidine ring also favors the approach of 
4-nitrobenzaldehyde towards enamine exclusively from the plane in 
which carboxylic acid is present. As shown in Figure 3.1, the cyclic 
bonded framework involves weak hydrogen bond interaction between 
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the carbonyl group of 4-nitro benzaldehyde and hydrogen of carboxylic 
acid. Having a substituent at position 5 on pyrrolidine ring would 
promote the re facial attack of enamine on the aldehyde, but not the 
weak hydrogen bond itself that promotes the attack. 
3.3 Results and Discussion: 
3.3.1 Mannich Reaction 
3.3.1.1 Mannich Reaction catalyzed by (3R, 5S)-5-benzyl-3-
methylpyrrolidine-3-carboxylic acid, (3R, 5S)-10c: 
Mannich reaction was performed between isovaleraldehyde and a 
prepared N-PMP protected α-imino ester as shown in Scheme 3.2. The α-imino 
ester was prepared fresh from ethyl glyoxylate and p-anisidine before use 
according to the reported procedure.50 
 
Scheme 3.2 Mannich reaction between isovaleraldehyde and α-imino ester 
We have performed the above Mannich reaction with L-proline catalyst 
and we used as reference to compare our results to. We have tested both β-
proline analogues that were designed by us in the Mannich reaction. We have 
chosen to perform these reactions in methylene chloride (ε = 9.08) which is 
relatively non polar compared to DMSO (ε = 47), that was used for L-proline. The 
Mannich reaction when performed with 20 mol% of L-proline as catalyst in 
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DMSO, provided syn-Mannich product in 96% yield. The reaction time for this 
reaction was observed to be 4 hrs. The diastereomeric ratio of the product was 
determined from 1H NMR analysis and it was found to be to be 24:1(syn: anti). 
The enantiomeric excess of the syn-Mannich product was determined to be 97% 
and it was determined by HPLC using chiral stationary phase. (Table 3.1)  
Table 3.1  
Mannich reaction between isovaleraldehyde and α-imino ester catalyzed by L-
proline and designed β-proline analogue, (3R, 5S)-10c 
 
Catalyst 
 
Loading 
 
Solvent 
(Dielectric 
Constant, ε) 
 
Time 
 
Yielda 
 
d.rb 
 
%eec 
 
Major 
Product 
 
L-proline 
 
20 mol% 
 
DMSO 
(ε = 47) 
 
4h, 
RT 
 
96% 
 
24:1 
(syn) 
 
97% 
 
(2S,3S)-
syn-13 
 
 
 
 
 
 
 
(3R, 5S)-
10c 
 
 
5 mol% 
 
DMSO 
(ε = 47) 
 
6h, 
RT 
 
79% 
 
4:1 
(anti) 
 
9% 
 
(2R,3S)-
anti-13 
 
5 mol% 
 
i-PrOH:CH2Cl2 
1:1 
(εi-ProH = 18.3) 
 
2h, 
RT 
 
82% 
 
19:1 
(anti) 
 
11% 
 
(2S,3R)-
anti-13 
 
5 mol% 
 
CH2Cl2 
(ε = 9.08) 
 
5h, 
RT 
 
82% 
 
19:1 
(anti) 
 
32% 
 
(2S,3R)-
anti-13 
a) % yield calculated from the product isolated after flash column chromatography 
b) Diastereomeric ratios determined from 1H NMR of crude product 
c) % ee determined from HPLC analysis using chiral stationary phase 
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When the Mannich reaction was performed using 5 mol% of (3R, 5S)-5-
benzyl-3-methylpyrrolidine-3-carboxylic acid (10C) in DMSO, the reaction went to 
completion in 6 hrs yielding 79% of product in a d.r. of 4:1(anti: syn). However, 
the enantiomeric excess of the anti-Mannich product was observed to be 9% ee. 
At this point we thought the solubility of the catalyst might be an issue because 
the catalyst, in its zwitterionic form, was not soluble in any solvents. Finally we 
found that the catalyst was completely soluble in 1:1 mixture of i-PrOH: CH2Cl2. 
Under these solvent conditions and 5 mol% catalyst loading, the reaction went to 
completion within 2 hrs providing 82% of the product in a d.r. of 19:1(anti: syn). 
However, the %ee of the anti-Mannich product did not show any significant 
improvement, providing 11% ee.  
We have repeated the Mannich reaction using methylene chloride as 
solvent and 5 mol% catalyst. The catalyst was not soluble in the solvent by itself, 
but after the addition of isovaleraldehyde and stirring for few minutes, the catalyst 
appeared to be completely soluble in the reaction mixture. This could possibly be 
due to the formation of enamine between catalyst and isovaleraldehyde. In 
methylene chloride the reaction went to completion after 5 hrs, yielding 82% of 
product. This reaction yielded anti-Mannich product in a d.r. of 19:1. The % ee of 
anti-product in the reaction showed significant improvement from the previous 
two reactions providing 32% ee. After observing the poor enantioselectivities of 
anti-Mannich products in the Mannich reactions catalyzed by the designed β-
proline analogue (3R, 5S)-10c, we proposed a transition state model that would 
explain for the enantioselective outcomes in the performed Mannich reaction. 
 89 
The transition state model is shown in Figure 3.2, is based on the enamine 
catalysis mechanism by L-proline. 
 
Figure 3.2  Proposed transition state model for the Mannich reaction catalyzed by 
designed analogue, (3R, 5S)-10c 
According to enamine mechanism, in the transition state of Mannich 
reaction catalyzed by (3R, 5S)-10c, the enamine formed between catalyst’s 
amine and isovaleraldehyde attacks the preformed imine. This attack should be 
facilitated by the carboxylic acid group of the catalyst. The carboxylic acid’s 
proton serves as a hydrogen bond donor to the imine, which is a very strong 
hydrogen bond acceptor. This strong hydrogen bond interaction should facilitate 
selective attack of enamine on particular face of the imine. As a result of this 
selective attack of enamine on the imine, the products are formed in an 
enantioselective fashion. 
If we consider the transition state of Mannich reaction, catalyzed by (3R, 
5S)-10c both benzyl substituent of amino acid and carboxylic acid group are in 
the same plane. When the incoming imine is approaching the enamine, it should 
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be directed by carboxylic acid of the amino acid. In this particular case, as shown 
in Figure 3.2, the benzyl group of the catalyst that is in the same plane as 
carboxylic acid is creating lot of steric congestion. We believe that as a result of 
this steric repulsion between the N-PMP group of imine and the benzyl 
substituent of the catalyst, the hydrogen bonding interaction between carboxylic 
acid and the imine may have been diminished. Since there is no factor, 
controlling the selective attack of enamine on the imine, the products obtained 
would usually be racemic.  
Interestingly, (3R, 5S)-10c catalyzed Mannich reaction showed some 
enantioselectivity in the anti-Mannich product when a relatively non-polar solvent 
(CH2Cl2) was used. When the reaction was performed in DMSO (ε = 47), the (2R, 
3S)-anti-13 Mannich product (d.r = 4:1) was formed in 9% ee. When the reaction 
was performed in a 1:1 mixture of 2-propanol/CH2Cl2, (2S, 3R)-anti-13 Mannich 
product, (d.r = 19:1) was formed in 11% ee. Improvement in diastereomeric 
excess was observed in this case and a switch in the enantioselectivity of the 
anti-Mannich product was observed. When the reaction was performed in CH2Cl2 
(ε = 9.08), (2S, 3R)-anti-13 Mannich product, (d.r = 19:1) was produced in 33% 
ee. Although the observed enantiomeric excess is not very significant, it is 
interesting that the enantioselectivity of the Mannich reaction catalyzed by (3R, 
5S)-10c is dependent on the nature of solvent used in the reaction.  
 
 
 91 
3.3.1.2 Mannich Reaction catalyzed by (3S, 5S)-5-benzyl-3-
methylpyrrolidine-3-carboxylic acid, (3S, 5S)-10c: 
We had performed the Mannich reaction (Scheme 17) by using the 
designed catalyst, (3S, 5S)-10c. The designed amino acid (3S, 5S)-10c provided 
“anti” selective Mannich products in excellent diastereoselectivities. (Table 3.2) 
The reactions were performed in methylene chloride solvent and at room 
temperature. We were able to carry out two reactions at different catalyst 
loadings. The diastereoselectivities of the Mannich products were determined 
from 1H NMR and the enantioselectivities were determined from HPLC analysis 
using a chiral stationary phase. 
Table 3.2  
Mannich reaction between isovaleraldehyde and α-imino ester catalyzed by L-
proline and designed β-proline analogue, (3S, 5S)-10c 
 
Catalyst 
 
Loading 
 
Solvent 
 
Time 
 
Yielda 
 
d.rb 
 
%eec 
 
Major Product 
 
L-Proline 
 
20 mol% 
 
DMSO 
 
4h, RT 
 
96% 
 
24:1 
(syn) 
 
97% 
 
(2S,3S)-syn-13 
 
 
 
(3S, 5S)-
10c 
 
1 mol% 
 
CH2Cl2 
 
 
2.5h, RT 
 
85% 
 
24:1 
(anti) 
 
98% 
 
(2R,3S)-anti-13 
 
5 mol% 
 
CH2Cl2 
 
2.5h, RT 
 
92% 
 
24:1 
(anti) 
 
99% 
 
(2R,3S)-anti-13 
a) % yield calculated from the product isolated after flash column chromatography 
b) Diastereomeric ratios determined from 1H NMR of crude product 
c) % ee determined from HPLC analysis using chiral stationary phase 
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Mannich reaction when performed with 5 mol% catalyst loading in 
methylene chloride at room temperature, the reaction went to completion in 2.5 
hrs. The reaction yielded anti-Mannich product in 92% yield and a diastereomeric 
ratio of 24:1 as determined from 1H NMR. The enantiomeric excess of the anti-
Mannich products was observed to be 99% as determined by HPLC analysis. We 
have then repeated the reaction with catalyst (3S, 5S)-10c at 1mol% loading. 
The reaction was carried out in methylene chloride at room temperature and it 
went to completion in 2.5 hrs. This reaction was worked up and the product was 
isolated in 85% yield. This reaction also provided anti selective Mannich products 
in a d.r. of 24:1. The enantiomeric excess of the anti-Mannich product was 
observed to be 98%. Even at 1 mol% loading, the catalyst (3S, 5S)-10c retained 
its efficiency in providing stereoselective products. To explain the observed 
enantioselectivity in the Mannich reaction, we proposed a transition state model 
based on the enamine mechanism. (Figure 3.3) 
 
Figure 3.3 Proposed transition state model for the Mannich reaction catalyzed by 
designed analogue (3S, 5S)-10c 
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In the transition state of Mannich Reaction enamine’s selective attack on 
the imine is facilitated by strong hydrogen bonding interaction between carboxylic 
acid moiety of the catalyst and the imine as shown in Figure 3.3. The enamine 
formed during the reaction will be in a particular conformation as shown in Figure 
3.3. The bulky benzyl substituent on the pyrrolidine ring blocks the back side face 
of enamine forcing the imine to approach the enamine from the top face. When 
this happens, the carboxylic acid group of the catalyst that is shown to be 
projecting out of the plane forms a hydrogen bond with the imine and holds it in 
the least energy conformation (anti) to avoid steric hindrance. As a result of this 
hydrogen bonding interaction, the enamine attacks the imine from one face. This 
selective facial attack yields enantioselective products in the reaction. 
3.3.2 Aldol Reaction catalyzed by (3S, 5S)-5-benzyl-3-methylpyrrolidine-3-
carboxylic acid, (3S, 5S)-10c: 
We performed the Aldol reaction between acetone and 4-
nitrobenzaldehyde using L-proline and (3S, 5S)-5-benzyl-3-methylpyrrolidine-3-
carboxylic acid as a catalysts. The Aldol reaction with L-proline was used as 
reference to our studies. The reaction using the designed amino acid (3S, 5S)-
10c did not proceed at all when the reaction was performed in acetone or DMSO. 
The reaction was monitored for up to 3 days by TLC and also mini work ups were 
performed at regular intervals to see if there was any progress. Upon careful 
observation of the reaction mixture, we could still see the catalyst insoluble in the 
solution. We thought that the solubility of the catalyst may be the reason for the 
poor reactivity. Then we have performed the reaction using D2O as solvent and 
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the reaction went to completion within a couple of hours.106 The reaction was 
worked up and pure Aldol product was isolate in 86% yield after flash column 
chromatography. However, this reaction yielded racemic mixture of the Aldol 
product. (Table 3.3) HPLC using chiral stationary phase was performed to 
determine the % enantiomeric excess of the Aldol product. 
Table 3.3  
Catalytic studies of Aldol reaction between acetone and 4-nitrobenzaldehyde 
 
Catalyst 
 
Solvent 
(20 vol% acetone) 
 
Loadings 
 
Time 
 
Yielda 
 
% eeb 
 
L-proline 
 
DMSO 
 
30 mol% 
 
3 hrs. 
 
72% 
 
72% 
 
 
 
(3S, 5S)-
10c 
 
DMSO 
 
6 mol% 
 
3 days 
 
- 
 
- 
 
D2O 
 
1 mol% 
 
1.5 hrs. 
 
86% 
 
Racemic 
 
CD2Cl2 
(4 vol% Water) 
 
1 mol% 
 
3 days 
 
- 
 
- 
a) % yield calculated from the product isolated after flash column chromatography 
b) % ee determined from HPLC analysis using chiral stationary phase 
The Aldol reaction between acetone and 4-nitro benzaldehyde using the 
designed β-proline analogue (3S, 5S)-10c did not proceed at all when performed 
in solvents such as DMSO or methylene chloride-D2. Reaction went to 
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completion within 2 hrs when D2O was used as a solvent, providing racemic 
mixture of aldol product. After observing the experimental results of the Aldol 
reaction catalyzed by (3S, 5S)-10c, we reexamined our hypothesized transition 
state for the reaction.  
We hypothesized that, in the Aldol reaction catalyzed by the designed β-
proline analogue (3S, 5S)-10c the selective facial attack of the enamine on 4-
nitrobenzaldehyde would be facilitated by the steric hindrance created by the 
benzyl group at position 5 of the pyrrolidine ring. Since a strong hydrogen bond 
acceptor is absent in the incoming aldehyde, the carboxylic acid of the amino 
acid (3S, 5S)-10c, could not direct the aldehyde via a hydrogen bonding 
interaction as seen with L-Proline where a stable six membered ring formation is 
observed in the transition state.17 In the designed β-proline analogue (3S, 5S)-
10c the benzylic substituent and the carboxylic acid moiety are in the opposite 
planes According to our hypothesis, the bulky benzyl group on the amino acid, 
(3S, 5S)-10c should block one face of enamine and force 4-nitro benzaldehyde 
to approach the enamine only from the opposite plane in which carboxylic acid 
group is present. The carboxylic acid should then provide a weak hydrogen bond 
and direct the aldehyde towards the enamine facilitating selective facial attack 
that would result in the formation of enantioselective products. However, the 
results of Aldol reaction between acetone and 4-nitrobenzaldehyde catalyzed by 
(3S, 5S)-10c suggests that the steric hindrance created by the benzyl group is 
not resulting in the selective attack of enamine on the aldehyde. 
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When the reaction was performed in less polar solvents such as DMSO or 
methylene chloride the reaction showed no progress even after prolonged 
reaction times (up to 3days) but when water was used as solvent, the reaction 
went to completion within couple of hours providing racemic mixture of Aldol 
product. After examining the reaction mechanism we were able to come up with 
a possible reasons for the observed poor results with water as solvent.  
We speculate that the weak hydrogen bonding interaction between 
carboxylic acid and the aldehyde is not taking place. In the L-proline catalyzed 
Aldol reaction the selective facial attack of enamine on the aldehyde is facilitated 
by weak hydrogen bond that is a part of stable six membered ring. With the 
designed β-proline amino acid (3S, 5S)-10c, in the transition state the cyclic 
hydrogen bonded frame work formation may not be taking place. If the weak 
hydrogen bonding interaction between the aldehyde and carboxylic acid group is 
absent in the transition state, the enamine’s attack on the aldehyde might not be 
selective. The aldehyde approaches from both planes towards the enamine that 
would result in both re and si-facial selectivities and as a result, the reaction 
provides a racemic mixture of products. 
3.4 Experimental Methods 
All anhydrous solvents were obtained by passage through a column of 
activated silica. Flash column chromatography was performed using SiliaFlash® 
P60 40-63µm (230-400 mesh) silica gel. NMR experiments were performed on a 
Bruker 400 MHz NMR instrument and chemical shifts were reported with 
reference to TMS (for CDCl3). All the organocatalytic reactions were performed in 
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a 5 mL sealed reaction tube at room temperature. The Imine for Mannich 
reactions was readily prepared from ethyl glyoxylate and p-anisidine before 
use.107  
3.4.1 Typical procedure for Mannich reactions: 
 
0.207 g (1.0 mmol) of the preformed imine (11) was weighed and added to 
a 5 mL sealed tube containing 2 mL anhydrous methylene chloride. Then 
appropriate amount of catalyst was weighed and added to the reaction vessel 
followed by 0.173 g (2.0 mmol) of isovaleraldehyde (12) as a solution in 2.0 mL 
of anhydrous methylene chloride. The reaction tube was tightly sealed and left to 
stir at room temperature. The reaction was monitored by TLC for the 
disappearance of Imine, 11. Once all the starting material had disappeared, the 
reaction mixture was washed with saturated NaCl (1 x 5 mL). The organic portion 
was dried over MgSO4, filtered and the solvent was removed under vacuum to 
afford crude product. Crude product was analyzed by 1H NMR to determine 
diastereomeric ratio of the Mannich product. The crude product was then purified 
immediately by flash column chromatography (20% ethyl acetate/80% hexanes) 
to provide pure product. The % yield of the reaction was determined from the 
pure product isolated in the reaction. The pure product was immediately 
analyzed by the HPLC using chiral stationary phase to determine the percent 
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enantiomeric excess. The data of the products was compared to the reported to 
the literature and determined to be consistent.50,51,101    
Compound 11, Imine for Mannich reaction:107 
To a 100 mL sealed tube 3.00g of molecular sieves, 4 Å were added and 
a stir bar was placed in the sealed tube. 0.992g (8.0 mmol) of p-anisidine was 
weighed and added to the above sealed tube. 25 mL of anhydrous methylene 
chloride was added to the reaction tube and the contents were stirred for 5 
minutes. 3.3g (16.0mmol) of ethyl glyoxylate (50% Vol/Vol in toluene) was added 
to the reaction tube and the tube was tightly sealed. The contents of the reaction 
tube were left to stir for 3 hrs at room temperature. Then the reaction mixture was 
filtered under vacuum to remove molecular sieves and the solvent was removed 
under vacuum to provide crude product as brownish –yellow liquid. Crude 
product was then purified by flash column chromatography (30%ethyl 
acetate/70% hexanes)/4%triethylamine to provide 1.49 g (7.19 mmol) pure 
product as light yellow liquid in 90%yield. The 1H NMR data is consistent with the 
product as reported.50,107 1H NMR (400 MHz, CDCl3) δ 7.94 (s, 1H), 7.40 – 7.33 
(m, 2H), 6.97 – 6.90 (m, 2H), 4.42 (q, J = 7.1 Hz, 2H), 3.84 (s, 3H), 1.41 (t, J = 
7.1 Hz, 3H). 
(2S, 3S)-syn-13, (2S,3S)-ethyl 3-formyl-2-(4-methoxyphenylamino)-4-
methylpentanoate: 
In the Mannich reaction, (2S, 3S)-syn-13 product was prepared by using 
L-proline as catalyst in 20 mol% loading in DMSO. The reaction was set up 
worked up according to the common procedure reported for the Mannich reaction 
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between preformed α-imino ester and isovaleraldehyde. The product was 
characterized by 1H NMR and chiral stationary phase HPLC analysis. HPLC was 
performed using Daicel Chiralpak AS-H column (4.6mm x 250mm, 5 µ). 1H NMR 
(400 MHz, CDCl3) δ 9.78 (d, J = 3.0 Hz, 1H), 6.81 – 6.73 (m, 2H), 6.70 – 6.62 (m, 
2H), 4.32 (dd, J = 10.3, 6.8 Hz, 1H), 4.20 – 4.11 (m, 2H), 3.85 (d, J = 10.3 Hz, 
1H), 3.74 (s, 3H), 2.55 (td, J = 7.0, 3.1 Hz, 1H), 2.31 (dq, J = 13.9, 6.9 Hz, 1H), 
1.22 (td, J = 7.0, 3.1 Hz, 3H), 1.17 (d, J = 6.9 Hz, 3H), 1.03 (d, J = 6.8 Hz, 3H). 
HPLC (λmax = 254nm, flow rate = 1.0 mL/min, 1% i-PrOH / 99% Hexanes.): tR 
(major enantiomer, (2S, 3S)-syn-13) = 32.2 min. tR (minor enantiomer, (2R, 3R)-
syn-13) = 66.8 min.56 
(2R, 3S)-anti-13, (2R,3S)-ethyl 3-formyl-2-(4-methoxyphenylamino)-4-
methylpentanoate: 
In the Mannich reaction, (2R, 3S)-anti-13 product was prepared by using 
the designed catalyst. The reaction was set up and worked up according to the 
common procedure reported for the Mannich reaction between preformed α-
imino ester and isovaleraldehyde. The product was characterized by 1H NMR 
and chiral stationary phase HPLC analysis. HPLC was performed using Daicel 
Chiralpak AS-H column (4.6mm x 250mm, 5 µ).1H NMR (400 MHz, CDCl3) δ 9.74 
(t, J = 3.4 Hz, 1H), 6.80 – 6.73 (m, 2H), 6.70 – 6.62 (m, 2H), 4.39 – 4.30 (m, 1H), 
4.20 – 4.12 (m, 2H), 3.93 (d, J = 13.4 Hz, 1H), 3.74 (s, 3H), 2.59 (dddd, J = 13.3, 
9.9, 6.7, 3.2 Hz, 1H), 2.16 – 2.05 (m, 1H), 1.23 – 1.18 (m, 3H), 1.14 – 1.10 (m, 
3H), 1.07 (d, J = 6.9 Hz, 3H). HPLC (λmax = 254nm, flow rate = 1.0 mL/min, 1% i-
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PrOH / 99% Hexanes.): tR (major enantiomer, (2R, 3S)-anti-13) = 56.2 min. tR 
(minor enantiomer, (2S, 3R)-anti-13) = 29.1 min. 
(2S, 3R)-anti-13, (2S, 3R)-ethyl 3-formyl-2-(4-methoxyphenylamino)-4-
methylpentanoate: 
In the Mannich reaction, (2S, 3R)-anti-13 product was prepared by using 
the designed catalyst. The reaction was set up worked up according to the 
common procedure reported for the Mannich reaction between preformed α-
imino ester and isovaleraldehyde. The product was characterized by 1H NMR 
and chiral stationary phase HPLC analysis. HPLC was performed using Daicel 
Chiralpak AS-H column (4.6mm x 250mm, 5 µ).1H NMR (400 MHz, CDCl3) δ 9.75 
(d, J = 3.4 Hz, 1H), 6.81 – 6.73 (m, 2H), 6.71 – 6.62 (m, 2H), 4.33 (t, J = 13.5 Hz, 
1H), 4.19 – 4.13 (m, 2H), 3.94 (t, J = 11.5 Hz, 1H), 3.74 (s, 3H), 2.60 (ddd, J = 
7.7, 6.2, 3.4 Hz, 1H), 2.10 (tt, J = 10.9, 5.5 Hz, 1H), 1.23 – 1.17 (m, 3H), 1.13 (t, J 
= 6.1 Hz, 3H), 1.08 (d, J = 6.9 Hz, 3H). HPLC (λmax = 254nm, flow rate = 
1.0mL/min, 1% i-PrOH / 99% Hexanes.): tR (major enantiomer, (2S, 3R)-anti-13) 
= 24.9 min. tR (minor enantiomer, (2R, 3S)-anti-13) = 53 min. 
3.4.2 Typical procedure for Aldol reactions 
All the reactions were carried out in a 5 mL sealed tube. Catalyst was 
weighed and placed in the 5 mL sealed tube and 3.2 mL of appropriate solvent 
was added to it. Then 0.8 mL of Acetone was added to the above reaction 
vessel. The sealed tube was tightly capped and the contents were allowed to stir 
for 15 minutes at room temperature. Then 4-nitro benzaldehyde was added to 
the sealed tube and the reaction tube was tightly sealed and the reaction was left 
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to stir at room temperature. Once the reaction had gone to completion (TLC 
analysis), it was worked up by adding 10 mL of saturated ammonium chloride 
and the organic contents were extracted using ethyl acetate (2 x 15 mL). All 
organic portions were combined and dried over magnesium sulfate. Then 
magnesium sulfate was filtered off and the solvent was removed under vacuum 
to provide crude product as cherry red colored viscous liquid. The crude product 
was purified by gradient flash column chromatography (30% Ethyl acetate / 70% 
Hexanes to 50% Ethyl acetate / 50% Hexanes). The pure Aldol product was 
isolated as a light yellow crystalline solid and the % yield of the reaction was 
calculated from the amount of pure product isolated after flash column 
purification. The pure Aldol product was characterized by 1H NMR and chiral 
stationary phase HPLC analysis.12,17  
(R)-Aldol Product, (R)-4-hydroxy-4-(4-nitrophenyl) butan-2-one: 
Reaction was set up and worked up according to the above reported 
procedure for the Aldol reaction. Reaction catalyzed by L-Proline was performed 
and the data obtained was used as a reference to compare our results to.  Pure 
product was analyzed by 1H NMR and HPLC to determine purity and percent 
enantiomeric excess. HPLC was carried out using Daicel Chiralpak AS-H column 
(4.6mm x 250mm, 5 µ). 1H NMR (400 MHz, CDCl3) δ 8.22 (d, J = 8.7 Hz, 2H), 
7.54 (d, J = 8.7 Hz, 2H), 5.31 – 5.23 (m, 1H), 3.56 (d, J = 3.1 Hz, 1H), 2.92 – 
2.79 (m, 2H), 2.22 (s, 3H). HPLC (λmax = 280nm, flow rate = 1.0 mL/min, 15% i-
PrOH / 85% Hexanes.): Retention time of (R)-Aldol product is 24.4 min. and for 
(S)-Aldol product it is 34.3 min.
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CHAPTER IV  ENZYME MEDIATED CONCISE SYNTHESIS OF NH-FMOC-S-
TRITYL-Cα-METHYL CYSTEINE 
4.1 Hypothesis 3: 
A short, chiral auxiliary free synthetic route can be developed to prepare 
both enantiomers of orthogonally protected NH-Fmoc-S-Trityl-Cα-Methyl Cysteine 
using the enzyme Porcine Liver Esterase. 
4.2 Background 
4.2.1 Cysteines and analogues in peptide chemistry: 
There has been a growing demand for the orthogonally protected amino 
acids in the area of peptide synthesis. This is mainly due to the fact that the 
orthogonally protected amino acids can be used conveniently in the solid phase 
peptide synthesis as the protecting group removal can be performed under mild 
reaction conditions without affecting other groups on the peptide chain. Cysteines 
are widely used in the field of peptide chemistry due to their ability to form 
disulfide bonds that result in the folding of peptides.108-110 Cysteines with a methyl 
substituent at Cα-methyl position are widely used in the peptide chemistry in the 
place of natural cysteine. The amino acids with Cα-methyl substituent when 
incorporated into polypeptides restrict the conformational mobility of the peptide 
back bone that results in enhanced resistance to various chemical and enzymatic 
degradations.111-115 Moreover the Cα-methyl cysteine analogues are used as key 
components in the synthesis of various biologically potent compounds such as 
Largazoles,116,117 Mirabzoles,118-121 Tantazoles,122,123 Thiangazoles124-127 and 
their derivatives. In the recent work reported by Burlina et al, Cα-methyl 
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cysteine’s ability to from in situ thioesters was utilized in the process of protein 
ligation.128 
4.2.2 Synthesis of Cα-methyl cysteine: 
Cα-methyl cysteines have been reported to be widely used in peptide 
synthesis and there are various reported synthetic procedures to prepare them in 
their protected forms.129-136 Pattendan et al reported a stereoselective alkylation 
procedure for the synthesis of various Cα-alkylated cysteines by utilizing (R)-
cysteine methyl ester as the starting material.133 Kedrowski reported the 
synthesis of protected S-tert-butyl protected Cα-methyl cysteine methyl ester 
using an enzyme mediated asymmetric hydrolysis as a key step in the 
process.132 Later Masterson et al reported an improved method for the 
preparation of the Cα-methyl cysteine and used it for the solution phase synthesis 
of a glutathione analogue.80 Both procedures, reported by Kedrowski and 
Masterson utilize Porcine Liver Esterase to cause asymmetric transformation of 
malonate diester into a chiral malonate half-ester in a very selective fashion in an 
enantiomeric excess of >90%.  
Singh et al published a method for enantioselective synthesis of Cα-
methyl cysteine in orthogonally protected form that is suitable for solid phase 
peptide synthesis.131 The procedure reported by Singh et al utilizes chiral 
auxiliaries S and R- Camphorsultam to carry out a stereoselective alkylation 
reaction that resulted in the formation of a quaternary chiral center as shown in 
Scheme 4.1. The protecting groups on the amine and thiol groups of cysteine 
were installed in the later steps of the synthetic strategy. 
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Scheme 4.1 Synthesis of (S)-NH-Fmoc-S-Trityl-Cα-methyl cysteine (Singh et al) 
We have designed a synthetic route to the orthogonally protected α-methyl 
Cysteine amino acid that utilizes Porcine Liver Esterase to prepare 
enantioenriched half esters and the results of the work have been published.137 
4.3 Results and Discussion: 
Our initial approach to the orthogonally protected cysteine amino acid is 
as shown in Scheme 4.2. This method involves preparation of malonate diester 
with an S-trityl side chain and then subjecting it to asymmetric hydrolysis by PLE. 
For the preparation of malonate diester 15, Triphenylmethanethiol was treated 
with sodium hydride followed by addition of anhydrous methylene chloride to 
create alkylating agent 14. The chloride 14, was then reacted with the enolate of 
dimethyl methyl malonate to provide the diester 15. When the diester 15 was 
subjected to enzymatic hydrolysis by PLE, the reaction did not proceed. We 
hypothesized that this is due to the trityl group in the side chain being too large to 
fit in the active site of PLE.  
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Scheme 4.2 Attempted PLE hydrolysis of malonate diester with trityl group 
After our unsuccessful attempt to prepare the target cysteine amino acid, 
we decided to utilize the already established strategy79,80 to synthesize the 
enantioenriched chiral malonate half ester intermediates that can be transformed 
to Cα-methyl cysteine amino acid analogues.  
4.3.2 Synthesis of (R) NH-Fmoc-S-Trityl-Cα-Methyl Cysteine-OH: 
Malonate diester 15, was prepared and subjected asymmetric enzymatic 
hydrolysis by PLE according to the reported procedure.80,132 This reaction 
provided the product half ester in 77% yield and 94% ee. The enantioenriched 
chiral half ester 16 was subjected to a Curtius rearrangement in the presence of 
diphenyl phosphoryl azide and triethyl amine to provide the crude isocyanate. 
(Scheme 4.3) The crude isocyanate was isolated after a quick work up and 
reacted with 9-fluorenyl methanol in the presence of Titanium (IV) Isopropoxide. 
This reaction afforded the Fmoc protected amine81,138 in 46% yield, from the half 
ester 16. The amino ester 17, derived from the Curtius reaction was subjected to 
ester cleavage under refluxing acid conditions. To our surprise the NH-Fmoc 
group and S-tert-butyl groups remained intact under the harsh acid reflux 
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conditions of the reaction. Even though there are reports that suggest the S-tert-
butyl groups can be cleaved under refluxing acid conditions, this was not 
observed in this case.130,134  
For the deprotection of the S-tert-butyl group, we utilized a Mercury (II) 
Acetate / TFA / anisole cocktail. This reaction was carried out at room 
temperature and the resulting mercurial species were washed with ice cold ether 
to remove all the organic impurities. The resulting grey precipitate was taken up 
in methanol and H2S gas was bubbled through the solution for 30 minutes to 
reduce the mercurial species. The resulting solution was centrifuged to 
precipitate mercury sulfide and the solution was decanted. This decanted 
solution was then passed through a 2.0µ HPLC syringe filter to remove any 
traces of mercury that were still present after centrifugation. The free thiol 
compound produced was taken to the next step immediately without any 
intermediate purification. In the next step the free thiol from the S-tert-butyl 
deprotection step was reacted with triphenyl methanol in the presence of TFA to 
provide the (R) NH-Fmoc-S-Trityl-Cα-Methyl Cysteine-OH (R)-19, in 59% yield, 
over two steps from 18. (Scheme 4.3) 
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Scheme 4.3 Synthesis of (R) NH-Fmoc-S-Trityl-Cα-Methyl Cysteine-OH 
The orthogonally protected amino acid was purified by reverse phase 
HPLC. Chiral HPLC analysis was performed on this purified product and the 
enantiomeric excess was found to be 94%. Upon further purification by 
recrystallization in acetonitrile/water mixture, the protected Cysteine amino acid 
(R)-19 was isolated in >99% enantiomeric excess. The improvement in the % ee 
was determined from the HPLC analysis using chiral stationary phase.   
4.3.3 Synthesis of (S) NH-Fmoc-S-Trityl-Cα-Methyl Cysteine-OH: 
Malonate half ester 16 from PLE hydrolysis was transformed into tert-butyl 
half ester 20 according to the reported procedure.132 Half ester 20 was then 
subjected to a Curtius rearrangement using diphenylphosphorylazide and 
triethylamine to provide isocyanate. (Scheme 4.4) The crude isocyanate was 
isolated and quickly taken to next step, reaction with 9-Fluorenylmethanol in the 
presence of Titanium (IV) Isopropoxide. This reaction yielded NH-Fmoc protected 
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amine compound 21 in 51 % yield over two steps. In the next step both CO2-tert-
butyl and S-tert-butyl groups were cleaved when compound 21 was treated with 
Mercury (II) Acetate / Anisole / TFA cocktail followed by the bubbling of H2S gas. 
The work up procedure for the mercurial is similar to that of the compound 18. 
The S-tert-butyl deprotected NH-Fmoc-Cα-methyl-Cys-OH was isolated and 
reacted immediately with triphenylmethanol in the presence of TFA to provide (S) 
NH-Fmoc-S-Trityl-Cα-Methyl Cysteine-OH, (S)-19 in 82% yield. The compound 
(S)-19 was analyzed by chiral stationary phase analysis and the % ee was 
determined to be 92%. This compound was further recrystallized from the 
acetonitrile/water mixture to provide essentially enantiopure (S)-19 in >99% ee. 
 
Scheme 4.4 Synthesis of (S) NH-Fmoc-S-Trityl-Cα-Methyl Cysteine-OH 
4.4 Experimental Methods 
4.4.1 General experimental information 
All anhydrous solvents were obtained by passage through a column of 
activated silica. Flash column chromatography was performed using SiliaFlash® 
P60 40-63µm (230-400 mesh) silica gel. NMR experiments were performed on a 
Bruker 400 MHz NMR instrument and chemical shifts were reported with 
reference to either TMS (for CDCl3) or residual solvent proton peak (for CD3OD). 
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Infra-Red analysis was performed on a Thermo Nicolet nexus 470 FT-IR 
instrument. Melting point analysis was performed using Thomas-Hoover “Uni-
Melt” Melting Point Apparatus. High Resolution mass spectra were obtained 
using positive electrospray ionization on a Bruker 12 Tesla APEX -Qe FTICR-MS 
with an Apollo II ion source. The % ee of the final product was determined by 
chiral HPLC analysis. 
Chiral stationary phase HPLC: Chiral HPLC was performed using a Chiralpak 
AD-H column (4.6mm x 250mm, 5 µ), λmax = 256nm, flow rate = 1.0 mL/min, 10% 
i-PrOH / 90% hexanes. Retention times for R enantiomer = 7 min and S 
enantiomer = 9 min. 
Reverse Phase HPLC: Reverse phase HPLC was carried out on Vydac C18 
column (250mm x 10mm, 10µ) using a linear solvent gradient, 95% Solvent A / 
5% Solvent B to 5% Solvent A / 95% Solvent B in 45 min. (λmax = 256nm, flow 
rate = 5 mL/min). Retention time of the product is 35 min.  
Solvent A = Water (1% TFA)  
Solvent B = Acetonitrile (1% TFA)  
14, (Chloromethyl)(Trityl) sulfane: 
1.605g (0.4015mol) of NaH was placed in a 1000 mL, three neck round 
bottom flask under N2 atmosphere at 0 oC. NaH was washed twice with pentane 
to remove the mineral oil. Then 100 mL of anhydrous THF was added to the 
above reaction flask containing the NaH. The contents were stirred for 5 minutes 
and 10 g (0.0362mol) of Triphenylmethanethiol was added slowly to the reaction 
flask. The reaction mixture was continued to stir at 0 oC under N2 atmosphere for 
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5 minutes. Then 500 mL of anhydrous dichloromethane was added to the flask 
and the resulting mixture was stirred overnight and became cloudy. The resulting 
mixture was filtered and washed with water (1 x 300 mL) followed by saturated 
NaCl (1 x 300 mL). The organic layer was dried over MgSO4, filtered, and the 
solvent was removed under vacuum to provide 10.02g (0.031mol) of 14 as a light 
yellow colored solid in 86% yield. M.P. = 101-102 oC. IR (cm-1) 3055, 2922. 1H-
NMR (400 MHz, CDCl3) δ 7.45 – 7.36 (m, 6H), 7.27 (m, 6H), 7.22 (m, 3H), 4.28 
(s, 2H). 13C-NMR (100 MHz, CDCl3) δ 143.86, 129.94, 128.22, 127.27, 69.42, 
48.16. 
15, Dimethyl 2-methyl-2-(tritylthiomethyl) malonate: 
0.150 g (6.22 mmol) NaH (60% dispersion in mineral oil) was placed in a 
100 mL, three neck round bottom flask at 0 oC under a N2 atmosphere. The NaH 
was washed with pentane (2 x 5 mL), to remove mineral oil and pentane layers 
were decanted. 10 mL of anhydrous THF was added to the reaction flask and the 
contents were stirred for 5 minutes. Then 0.542g (3.11 mmol) of 
diethylmethylmalonate was added, as a solution in 5 mL of anhydrous THF, to 
the above reaction flask slowly in a dropwise manner using a gas tight syringe. 
The resulting mixture was stirred for 30 minutes at 0 oC under a N2 atmosphere. 
The mixture was brought to room temperature and allowed to stir for another 30 
minutes. Then 1.01 g (3.11 mmol) of 14 was added to the reaction flask, as a 
solution in 7 mL of anhydrous THF, using a gas tight syringe. The reaction was 
allowed to stir at room temperature for 5 minutes and then the reaction mixture 
was heated to reflux solvent for 24 hrs. The resulting mixture was cooled to room 
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temperature and poured onto ice. The mixture was extracted with diethyl ether (3 
x 35 mL). The ether portions were combined, dried over MgSO4 and the solvent 
was removed under vacuum to provide crude product as a viscous yellow liquid. 
The crude material was purified by flash column chromatography (7% ethyl 
acetate/93% hexanes; Rf = 0.22) to provide 0.75 g (1.62 mmol) of 15 as white 
crystalline solid in 52% yield. M.P. = 116-117 oC. IR (cm-1) 3055, 2976, 1726, 
1750. 1H-NMR (400 MHz, CDCl3) δ 7.44 – 7.41 (m, 5H), 7.30 – 7.23 (m, 7H), 
7.22 – 7.18 (m, 3H), 4.20 – 4.10 (m, 4H), 2.62 (s, 2H), 1.32 (s, 3H), 1.21 (t, J = 
7.1 Hz, 6H). 13C-NMR (100 MHz, CDCl3) δ 170.92, 144.45, 129.60, 127.87, 
126.69, 66.55, 61.53, 53.42, 36.65, 19.51, 13.97.  
16, (R)-2-(tert-butylthiomethyl)-3-methoxy-2-methyl-3-oxopropanoic acid:  
Compound 16 was prepared via asymmetric enzymatic hydrolysis using 
crude PLE according to the reported procedure.79,132 1.0 L phosphate buffer of 
pH 7.4 was placed in a 2.0 L beaker. 53.0 g (213.42 mmol) of malonate diester 
15 was added along with 5 mL of ethanol (0.5 vol %) to the above beaker under 
constant stirring. Then 1.07g (18 units/mg, 90 units/mmol of diester) of crude 
Porcine Liver Esterase (PLE) enzyme was added to the above reaction beaker 
and the reaction was continued to stir vigorously. The pH of the reaction was 
maintained at 7.4 using an auto titrator that was set to deliver 1.0 M NaOH as the 
reaction progressed. The reaction went to completion within 2 days. The pH of 
the reaction was brought up to 9.0 and a quick extraction was performed with 
ethyl acetate (1 x300 mL). The aqueous portion was filtered through a celite bed 
under vacuum to remove the enzyme and then acidified to pH 2.0 using 12M 
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HCl. The organics were extracted with diethyl ether (4 x 500 mL). The resulting 
organic layers were combined and washed with brine (1 x 600 mL), dried over 
MgSO4, filtered and solvent was removed under vacuum to provide 38.6g (165 
mmol) of  essentially pure 16 in 77%yield and 94% ee ( determined from chiral 
phase HPLC of compound I prior to recrystallization). Proton and carbon NMR 
data matches to that of the literature.79,132 
17, (R)-Methyl 2-(((9H-fluoren-9-yl) methoxy) carbonylamino)-3-(tert-butylthio)-2-
methylpropanoate: 
To a 100 mL, three neck round bottom flask under a N2 atmosphere, 
2.343 g (10.00 mmol) of chiral half ester 16 was added as a solution in 40 mL 
anhydrous 1,2-dichloroethane. 1.67 mL (12 mmol) of triethylamine was added 
and the mixture was stirred for 10 min. at room temperature. Then 2.94 g (10.68 
mmol) of diphenylphosphorylazide was added and the reaction mixture was 
allowed to stir at room temperature under N2 for 2 hrs. The resulting mixture was 
then heated to solvent reflux for 4 hrs at which point it was determined that the 
azide had been completely consumed (IR analysis). The reaction mixture was 
cooled to room temperature and washed quickly with saturated NH4Cl solution (1 
x 40 mL). The organic portion was dried over MgSO4, filtered and solvent was 
removed under vacuum to afford crude isocyanate as a murky brownish oil. The 
crude isocyanate was placed immediately in a 100 mL one neck round bottom 
flask, under a N2 atmosphere, as a solution in 40 mL of freshly distilled toluene. 
To the reaction flask containing crude isocyanate, 2.55 g (13 mmol) of 9-
Fluorenemethanol was added and the contents were allowed to stir for 5 min. 
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Then 0.190 mL (0.630 mmol) of Titanium (IV) Isopropoxide was added to the 
reaction flask and the reaction mixture was heated to 83 0C using an oil bath. 
The resulting mixture was allowed to heat for 15 hrs under a N2 atmosphere. The 
mixture was cooled to room temperature and the solvent was removed under 
vacuum to provide crude product. This crude product was taken up in diethyl 
ether (25 mL) and washed with water (2 x 20 mL) followed by saturated NaCl (1 x 
25 mL). The organic layer was dried over MgSO4 and the solvent was removed 
under vacuum to provide a viscous yellow oil. The crude product was then 
purified by flash column chromatography (30% diethyl ether / 70% hexanes; Rf = 
0.24) to provide 1.97g (4.61 mmol) of NH-Fmoc S-tert-butyl Cys-OMe (17) as a 
clear viscous oil in 46% yield. [α]D23 = +4.3 (c = 1.0, CHCl3). IR (cm-1) 3350, 
2957, 1717. 1H-NMR (400 MHz, CDCl3) δ 7.74 (d, J = 7.5 Hz, 2H), 7.61 (d, J = 
7.2 Hz, 2H), 7.37 (t, J = 7.4 Hz, 2H), 7.29 (t, J = 7.4 Hz, 2H), 5.92 (s, 1H), 4.28 
(m, 3H), 3.79 (s, 3H), 3.37 (d, J = 11.7 Hz, 1H), 3.05 (d, J = 11.4 Hz, 1H), 1.64 (s, 
3H), 1.27 (s, 9H). 13C-NMR (100 MHz, CDCl3) δ 173.52, 154.55, 143.93, 143.85, 
141.24, 127.63, 127.03, 125.18, 119.91, 66.74, 59.78, 52.90, 47.09, 42.30, 
34.72, 30.79, 23.48. HRMS (C24H29NO4S Na+) calcd = 450.170950 m/z, obsd = 
450.170593 m/z. 
18, (R)-2-(((9H-fluoren-9-yl) methoxy) carbonylamino)-3-(tert-butylthio)-2-
methylpropanoic acid: 
0.440g (1.03 mmol) of NH-Fmoc S-tert-butyl Cα-Me-Cys-OMe (17) was 
dissolved in 15 mL of 1, 4-dioxane and transferred to a 100 mL three neck round 
bottom flask. Then 15 mL of 5.0N HCl was added and the flask was connected to 
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a reflux condenser and placed under a N2 atmosphere. The mixture was stirred at 
room temperature for 10 minutes and then heated to reflux solvent for 18 hrs. at 
which time the reaction had gone to completion. The mixture was cooled to room 
temperature and 25 mL of water was added. The organic contents were 
extracted with methylene chloride (3 x 25 mL). The organic portions were 
combined and washed with water (6 x 50mL) followed by saturated NaCl (2 x 50 
mL). The organic layer was dried over MgSO4, filtered and the solvent was 
removed under vacuum to provide 18 as a white solid in quantitative yield. M.P. = 
65-68 oC. [α]D24 = + 2.0 (c = 1.0, CH2Cl2). IR (cm-1) 2959, 1705, 1H-NMR (400 
MHz, CDCl3) δ 7.76 (d, J = 7.5 Hz, 2H), 7.61 (d, J = 7.2 Hz, 2H), 7.39 (t, J = 7.4 
Hz, 2H), 7.31 (t, J = 7.3 Hz, 2H), 6.99 (bs, 1H), 5.76 (s, 1H), 4.27 (m, 3H), 3.31 
(d, J = 10.9 Hz, 1H), 3.14 (d, J = 6.9 Hz, 1H), 1.69 (s, 3H), 1.29 (s, 9H). 13C-NMR 
(100 MHz, CDCl3) δ 177.87, 155.13, 144.07, 144.01, 141.50, 127.90, 127.30, 
125.39, 120.17, 67.23, 59.68, 47.31, 42.72, 34.86, 31.03, 23.65.HRMS 
(C23H27NO4S Na+) calcd = 436.155300 m/z, obsd = 436.155127 m/z. 
(R)-19, (R)-2-(((9H-fluoren-9-yl) methoxy) carbonylamino)-2-methyl-3-(tritylthio) 
propanoic acid: 
Step 1: S-tert-butyl deprotection 
0.582g (1.41 mmol) of compound 18 was placed in a 100 mL one neck 
round bottom flask and 20 mL of trifluoroacetic acid (TFA) was added. The 
mixture was stirred for 5 min and then 0.86 mL (7.9 mmol) of anisole was added. 
The mixture was stirred for 5 minutes and 1.10 g (3.4 mmol) of mercury (II) 
acetate was added. The flask was tightly sealed with a glass stopper and allowed 
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to stir for 3 hrs. at room temperature. After stirring for 3 hrs the TFA was removed 
under vacuum to provide the crude product as a brown syrup. Then 10 mL of 
cold diethyl ether was added to the flask, resulting in a gray precipitate, to 
remove the organic impurities and the ether layer was removed. The gray 
precipitate was washed with cold diethyl ether two additional times and the ether 
layers were decanted. N2 gas was blown down on the gray precipitate for 15 min. 
to remove traces of diethyl ether. The gray precipitate was then suspended in 20 
mL of methanol and H2S was bubbled through the methanolic solution for 30 min. 
H2S gas was generated by dripping conc. H2SO4 dropwise to Na2S at 0 oC under 
a N2 stream directed into the reaction flask using a Teflon cannula. A black 
precipitate immediately fell out of the solution indicating the formation of mercuric 
sulfide. After 30 min. of passing H2S gas through the solution, the cannula was 
removed and N2 gas was bubbled through the reaction for 15 min. to remove 
remaining H2S. The reaction mixture was centrifuged to precipitate mercuric 
sulfide. The clear supernatant liquid was removed and passed through a 2.0µ 
HPLC syringe filter to remove remaining fine particulate. The solvent was 
removed under vacuum to provide 0.400g of NH-Fmoc, Cα-Me-Cys-OH as a light 
brownish solid which was taken immediately to the tritylation procedure.  
Step 2: S-Tritylation 
0.400g (1.12 mmol) of NH-Fmoc, Cα-Me-Cys-OH, from the previous step, 
was dissolved in 20 mL of trifluoroacetic acid in a 100 mL, one neck round 
bottom flask. The mixture was allowed to stir for 5 min. and then 0.292 g (1.12 
mmol) of triphenylmethanol was added to the reaction flask in one portion. The 
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reaction flask was sealed tightly with a glass stopper and allowed to stir for 21 
hrs at room temperature. The solvent was removed under vacuum to provide the 
crude product as a brown syrup. The crude compound was dissolved in 
methylene chloride (20 mL) and washed with water (2 x 20 mL) followed by brine 
(1 x 20 mL). The organic layer was dried over MgSO4, filtered and solvent was 
removed to provide crude product as viscous light brown liquid. Crude material 
was later purified by gradient flash column chromatography (20% ethyl 
acetate/80% hexanes to 100% ethyl acetate) to provide product, I, as white solid 
in 59% yield. 62 mg of the pure product was subjected to further purification by 
reverse phase HPLC using a Vydac C18 (250 x 10 mm, 10 µ) column according 
to the reported method.131 The product was further recrystallized (74% recovery) 
from acetonitrile/water to provide amino acid, I, in >99% ee. M.P. = 186-188 oC 
(Lit.131 182-183 oC).  [α]D23 = +45.1 (c = 0.25, CH3OH) (Lit. 131 [α]D24 = +31.9, c = 
0.25, CH3OH). IR (cm-1) 3056, 1709. 1H-NMR (400 MHz, MeOD) δ 7.77 (d, J = 
7.5 Hz, 2H), 7.70 (d, J = 7.0 Hz, 2H), 7.36 (dd, J = 13.3, 7.5 Hz, 8H), 7.27 – 7.12 
(m, 12H), 4.34 – 4.22 (m, 3H), 3.13 (d, J = 11.6 Hz, 1H), 2.62 (d, J = 11.6 Hz, 
1H), 1.32 (s, 3H).13C-NMR (100 MHz, MeOD) δ 176.54, 156.90, 146.14, 145.28, 
145.22, 142.52, 130.74, 128.83, 128.74, 128.20, 127.73, 126.40, 120.87, 67.91, 
67.22, 59.68, 38.81, 23.69. HRMS (C38H33NO4S Na+) calcd = 622.202250 m/z, 
obsd = 622.201790 m/z. 
20, (S)-3-tert-butoxy-2-(tert-butylthiomethyl)-2-methyl-3-oxopropanoic acid: 
Compound 20 was prepared according to the reported procedure132 from 
chiral half ester 16. 
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21, (S)-Tert-butyl 2-(((9H-fluoren-9-yl) methoxy) carbonylamino)-3-(tert-butylthio)-
2-methylpropanoate: 
To a 100 mL, three neck round bottom flask under a N2 atmosphere, 2.0 g 
(7.23 mmol) of chiral tert-butyl half ester 20 was added as a solution in 35 mL of 
anhydrous 1,2-dichloroethane. 1.21 mL (8.68 mmol) of triethylamine was added 
to the flask and the mixture was stirred for 10 min. at room temperature. 1.67 mL 
(7.73 mmol) of diphenylphosphorylazide was added to the reaction flask and the 
reaction mixture was allowed to stir at room temperature under a N2 atmosphere 
for 2 hrs. The mixture was then heated to reflux solvent for 2.5 hrs under a N2 
atmosphere at which time the azide had been completely consumed. At this point 
the reaction mixture was cooled to room temperature and washed quickly with 
saturated NH4Cl solution (1 x 40 mL). The organic portion was dried over MgSO4, 
filtered and the solvent was removed under vacuum to afford crude isocyanate. 
The crude isocyanate was dissolved in 30 mL of freshly distilled toluene and 
transferred immediately to a 100 mL one neck round bottom flask under a N2 
atmosphere. To the reaction flask containing crude isocyanate, 1.84 g (9.4mmol) 
of 9-Fluorenemethanol was added and contents were allowed to stir for 5 min. 
Then 0.136 mL (0.46 mmol) of titanium (IV) isopropoxide was added to the 
reaction flask and the reaction mixture was heated to 83 0C using an oil bath. 
The mixture was allowed to heat over night under a N2 atmosphere. The mixture 
was cooled to room temperature and the solvent was removed under vacuum to 
provide crude product. This crude product was taken up in diethyl ether (25 mL) 
and washed with water (2 x 20 mL) followed by saturated NaCl (1 x 25 mL). The 
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organic layer was dried over MgSO4 and the solvent was removed under vacuum 
to provide the crude product as a viscous yellow oil. The crude product was then 
purified by flash column chromatography (10% diethyl ether / 90% hexanes; Rf = 
0.24) to provide 1.73g (3.68 mmol) of pure (S)-NH-Fmoc S-tert-butyl Cys-OMe 
(10 ) as a clear viscous liquid in 51% yield. [α]D23 = +5.6 (c = 1.0, CHCl3). IR (cm-
1) 3416, 2974, 1716. 1H-NMR (400 MHz, CDCl3) δ 7.75 (d, J = 7.5 Hz, 2H), 7.63 
(t, J = 6.4 Hz, 2H), 7.39 (t, J = 7.4 Hz, 2H), 7.30 (t, J = 7.4 Hz, 2H), 5.95 (s, 1H), 
4.44 – 4.18 (m, 3H), 3.44 (d, J = 11.8 Hz, 1H), 2.98 (d, J = 11.8 Hz, 1H), 1.66 (s, 
3H), 1.50 (s, 9H), 1.29 (s, 9H). 13C-NMR (100 MHz, CDCl3) δ 172.32, 154.66, 
144.28, 144.13, 141.46, 141.44, 127.81, 127.23, 125.52, 125.43, 120.09, 82.80, 
66.85, 60.09, 47.35, 42.28, 34.67, 31.07, 28.07, 23.91. HRMS (C27H35NO4S Na+) 
calcd = 492.217900 m/z, obsd = 492.217584 m/z. 
(S)-19, (S)-2-(((9H-fluoren-9-yl) methoxy) carbonylamino)-2-methyl-3-(tritylthio) 
propanoic acid: 
Step 1: S-tert-butyl deprotection 
0.68g (1.45mmol) of  compound 10, 0.924 g of mercury (II) acetate, 0.335 
mL of anisole and 40 mL of TFA. Tert-butyl deprotection procedure is same as 
that reported for I. In this reaction, both S-tert-butyl and CO2-tert-butyl groups 
were cleaved in one step to provide NH-Fmoc- Cα-Me-Cys-OH in quantitative 
yield. 
Step 2: S-Trityl Protection 
0.225g (0.63mmol) of NH-Fmoc- Cα-Me-Cys-OH was reacted with 0.158 g 
(0.6mmol) of triphenylmethanol in 20 mL of TFA according to the procedure 
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reported for S-Tritylation in the synthesis of compound I. After flash column 
purification, 0.295 g (0.492 mmol) of II was isolated in 82% yield.  This compound 
was further recrystallized (84% recovery) from acetonitrile/water to provide pure 
amino acid, II, in >99% ee as a white solid. M.P. = 186-189 OC (Lit.131 192 oC).  
IR (cm-1) = 3053, 1713. [α]D23 = -45.1 (c = 0.15, CH3OH). 1H-NMR (400 MHz, 
MeOD) δ 7.76 (d, J = 7.5 Hz, 2H), 7.68 (d, J = 6.8 Hz, 2H), 7.35 (dd, J = 16.2, 7.6 
Hz, 8H), 7.17 (m, 12H), 4.29 (dd, J = 18.4, 7.6 Hz, 3H), 3.14 (d, J = 11.6 Hz, 1H), 
2.62 (d, J = 11.6 Hz, 1H), 1.32 (s, 3H). 13C-NMR (100 MHz, MeOD) δ 176.50, 
156.89, 146.11, 145.25, 145.19, 142.50, 130.72, 128.83, 128.74, 128.19, 127.73, 
126.39, 120.87, 67.90, 67.23, 59.65, 38.79, 23.68. HRMS (C38H33NO4S Na+) 
calcd = 622.202250 m/z, obsd = 622.201790 m/z.  
Note: In the compounds containing Fmoc group, magnetically inequivalent 
aromatic carbons of the Fmoc group resulted in additional 13C resonances in the 
aromatic region of the spectra.139,140  
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CHAPTER V - CONCLUSIONS AND FUTURE DIRECTIONS 
5.1 Conclusions 
A diastereoselective synthetic methodology for (3R, 5S)-5-benzyl-3-
methyl-β-proline (3R, 5S)-10c and its diastereomer (3S, 5S)-5-benzyl-3-methyl-β-
proline (3S, 5S)-10c has been developed. In this synthetic strategy the enzyme, 
Porcine Liver Esterase has served as a valuable catalyst to cause 
diastereoselective transformations of novel branched and chiral malonate 
diesters.  
Methods for the preparation of malonate diesters, 4a-c, with highly 
branched side chains and a preexisting chiral center were developed. The 
method utilizes optically pure and relatively inexpensive amino acids as the 
starting materials. The diester substrates (4a-c) derived from the amino acids 
were subjected to asymmetric hydrolysis by PLE to cause diastereoselective 
transformations. This unique approach of having a preset chiral center in the 
diester molecule eliminated the concern of producing enantiomers during PLE 
hydrolysis reaction as the reaction provided two compounds that are 
diastereomers to one another. The diastereoselectivities in the half esters 
produced from PLE hydrolysis were determined the 1H NMR analysis of the 
crude product. This helped us avoid methods such as HPLC using a chiral 
stationary phase, which could be more expensive and also time consuming.   
Substrates 4a-c underwent hydrolysis by crude PLE enzyme to provide 
mixture of diastereomeric half esters. The initial reactions with diester substrates 
4b and 4c did not show good conversions. Cosolvent screening was performed 
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with substrates 4b and 4c to investigate optimum conditions that provided decent 
conversions and selectivities in the asymmetric hydrolysis with crude PLE. There 
was no significant improvement in the conversion of compound 4b under 
different cosolvent conditions.  
PLE isoenzyme studies were also performed on the malonate diester 
substrates 4b and 4c to improve the conversions in the hydrolysis reaction. PLE 
isoenzymes 1, 2 and 5 did not show any reactivity with diester substrate 4b. 
There was slight improvement in the conversion of diester 4b with isoenzymes 3 
and 6. However this improvement cannot be considered as significant as the 
yields on the reactions were under 30%. PLE isoenzymes 1 and 2 did not show 
any reactivity towards substrate 4c.Reversal of diastereoselectivity was observed 
in the case of substrate 4c with PLE isoenzymes 3 and 4. We have taken 
advantage of this selectivity reversal to synthesize the second diastereomer of 
the 5-benzyl substituted Cα-methyl- β-proline, (3S, 5S)-10c. 
 We have investigated the stereoselective cyclization reaction of two 
substrates 6b and 6c that provided the novel γ-lactams 7b and 7c. The 
cyclization reaction, however, was a very slow process and we speculate that 
this is due to the steric congestion caused by the bulky substituent adjacent to 
the nitrogen of phthalimide group. The novel γ-lactams derived from 
stereoselective cyclization reaction was then transformed into 5-benzyl 
substituted Cα-methyl-β-proline analogues (3R, 5S) and (3S, 5S)-10c. 
The prepared amino acid analogues (3R, 5S)-10c and (3S, 5S)-10c were 
tested for their catalytic properties in the Mannich reaction between 
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isovaleraldehyde and a preformed α-imino ester. Amino acid (3S, 5S)-10c 
catalyzed the Mannich reaction very efficiently providing excellent diastereo and 
enantio selectivities at 1% catalyst loadings when the reaction was performed in 
relatively non polar solvent, methylene chloride. Amino acid (3R, 5S)-10c, when 
used in the Mannich reaction, we saw good diastereoselectivities towards the 
anti-Mannich Products. However, the enantioselectivities in the reaction were 
observed to be poor due to steric crowding in the transition state. Solvent 
screening in the Mannich reaction using amino acid (3R, 5S)-10c suggested that 
there is significant improvement in the enantioselectivities when the reaction was 
performed in relatively non polar methylene chloride as compared to DMSO. This 
solvent dependence on enantioselectivities needs to be further investigated. 
The compound (3S, 5S)-10c was also tested for its activity in Aldol 
reaction between acetone and 4-nitro benzaldehyde. There was no progress in 
the reaction when performed in solvents such as DMSO or methylene chloride. 
However the reaction went to completion within two hours, when the reaction 
was performed in water yielding racemic mixture of products. The designed 
amino acid (3S, 5S)-10c is a very efficient catalyst in the anti-Mannich reaction 
between isovaleraldehyde and a preformed N-PMP protected α-imino ester. 
A short and convenient synthesis for the preparation of orthogonally 
protected NH-Fmoc-S-Trityl, Cα-methyl cysteine suitable for solid phase peptide 
synthesis was developed. This methodology involves the preparation of 
enantioenriched chiral malonate half-esters from asymmetric bio catalytic 
hydrolysis with the enzyme Porcine Liver esterase. Curtius rearrangement of the 
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half ester followed by Fmoc protection of amine in the presence of Titanium (IV) 
Isopropoxide in a single step was the crucial step in the process. A mild and 
quick S-tert-butyl deprotection was performed using Mercury (II) Acetate. A 
method to improve the enantiopurity of the orthogonally protected Cα-methyl 
cysteine by recrystallization has been developed. This optically pure and 
orthogonally protected amino acid is utilized in solid phase peptide synthesis for 
biological studies by our collaborators at University of Vermont and Virginia 
Commonwealth University. 
5.2 Future Directions 
The yields of PLE hydrolysis of the novel branched malonate diesters can 
be improved further. The reaction can be performed in the phosphate buffer with 
a significant excess of organic solvents such as 20% DMSO to see if there is any 
improvements in the conversions without affecting the diastereoselectivity of the 
reaction. The hydrazine hydrolysis reaction of malonate diester 4c that showed 
slight preference in cyclization towards one ethyl ester over the other needs to be 
investigated to understand the role of bulky benzyl substituent on the observed 
selective cyclization. 
The designed amino acid (3S, 5S)-10c can be tested for its use as 
catalyst in the Mannich reaction with various substrates. The designed amino 
acid can also be investigated for its catalysis in other reactions such as Michael 
reaction. Computational studies can be performed on the Aldol reaction between 
acetone and 4-nitro benzaldehyde catalyzed by the synthesized amino acid (3S, 
5S)-10c to investigate the observed poor outcomes of the reaction.
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APPENDIX A  
A.1 1H and 13C NMR Spectra 
 
 
Figure A.1 1H and 13C NMR Spectra of compound 2a 
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Figure A.2 1H NMR Spectrum of compound 2b 
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Figure A.3 1H and 13C NMR Spectra of compound 2c 
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Figure A.4 1H NMR Spectrum of compound 3a 
 
Figure A.5 1H NMR Spectrum of compound 3b 
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Figure A.6 1H NMR Spectrum of compound 3c 
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Figure A.7 1H and 13C NMR Spectra of compound 4a 
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Figure A.8 1H and 13C NMR Spectra of compound (2R, 4S)-5a 
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Figure A.9 1H and 13C NMR Spectra of compound 4b 
 132 
 
 
Figure A.10 1H and 13C NMR Spectra of compound (2R, 4S)-5b 
 133 
 
Figure A.11 1H NMR Spectrum of compound 4c 
 
Figure A.12 1H NMR Spectrum of compound (2R, 4S)-5c 
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Figure A.13 1H NMR Spectrum of compound (2R, 4S)-5c 
 
Figure A.14 1H NMR Spectrum of compound (2R, 4S)-5c 
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Figure A.15 1H NMR Spectrum of compound (2R, 4S)-5c 
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Figure A.16 1H and 13C NMR Spectra of compound (2S, 4S)-6b 
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Figure A.17 1H and 13C NMR Spectra of compound (2S, 4S)-6c 
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Figure A.18 1H and 13C NMR Spectra of compound (3R, 5S)-7b 
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Figure A.19 1H and 13C NMR Spectra of compound (3R, 5S)-7c 
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Figure A.20 1H and 13C NMR Spectra of compound (3S, 5S)-8c 
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Figure A.21 1H and 13C NMR Spectra of compound (3R, 5S)-9c 
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Figure A.22 1H and 13C NMR Spectra of compound (3R, 5S)-10c 
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Figure A.23 1H and 13C NMR Spectra of compound (3S, 5S)-7c 
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Figure A.24 1H and 13C NMR Spectra of compound (3R, 5S)-8c 
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Figure A.25 1H and 13C NMR Spectra of compound (3S, 5S)-9c 
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Figure A.26 1H and 13C NMR Spectra of compound (3S, 5S)-10c 
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A.1.2 2-D NMR Experiments of (3R, 5S)-7b 
 
 
Figure A.27  (3R, 5S)-7b showing proton assignments for 2-D NMR analysis 
 
Figure A.28 1H HOMO COSY NMR Spectrum of compound (3R, 5S)-7b 
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Figure A.29 Observed Key 2D-NOESY correlations in compound (3R, 5S)-7b 
 
Figure A.30 2-D NOESY NMR spectrum of compound (3R, 5S)-7b 
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A.2 1H NMR Data of PLE isoenzyme Studies 
A.2.1  1H NMR Data - PLE Isoenzyme Reactions of substrate 4c 
 
Figure A.31 1H NMR Data of half ester from PLE 3 hydrolysis of diester 4c 
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Figure A.32 1H NMR Data of half ester from PLE 4 hydrolysis of diester 4c 
 
Figure A.33 1H NMR Data of half ester from PLE 5 hydrolysis of diester 4c 
 151 
 
Figure A.34 1H NMR Data of half ester from PLE 6 hydrolysis of diester 4c 
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A.2.2 1H NMR Data - PLE Isoenzyme Reactions of substrate 4b 
 
Figure A.35 1H NMR Data of half ester from PLE 3 hydrolysis of diester 4b 
 
Figure A.36 1H NMR Data of half ester from PLE 4 hydrolysis of diester 4b 
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Figure A.37 1H NMR Data of half ester from PLE 6 hydrolysis of diester 4b 
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A.3 Mannich Reaction- 1H NMR and HPLC Data 
A.3.1 1H NMR Data 
 
 
 
Figure A.38 1H NMR of (2S, 3S)-syn-13 Mannich product 
Reaction conditions: 
Catalyst (mol %): L-proline (20 mol %) 
Reaction Solvent: Anhydrous DMSO 
Diastereomeric Ratio: 23:1(syn) 
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Figure A.39 1H NMR of (2R, 3S)-anti-13 Mannich product 
Reaction conditions: 
Catalyst (mol %): (3R, 5S)-10c (5 mol %) 
Reaction Solvent: Anhydrous DMSO 
Diastereomeric Ratio: 4:1(anti) 
 
 
 
 
 
 
 156 
 
Figure A.40 1H NMR of (2S, 3R)-anti-13 Mannich product 
Reaction conditions:  
Catalyst (mol %): (3R, 5S)-10c (5 mol %) 
Reaction Solvent: 2-Propanol: methylene chloride (1:1) 
Diastereomeric Ratio: 22:1(anti) 
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Figure A.41 1H NMR of (2S, 3R)-anti-13 Mannich product 
Reaction conditions: 
Catalyst (mol %): (3R, 5S)-10c (5 mol %) 
Reaction Solvent: Methylene Chloride 
Diastereomeric Ratio: 18:1(anti) 
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Figure A.42 1H NMR of (2R, 3S)-anti-13 Mannich product 
Reaction conditions: 
Catalyst (mol %): (3S, 5S)-10c (5 mol %) 
Reaction Solvent: Methylene Chloride 
Diastereomeric Ratio: 23:1(anti) 
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Figure A.43 1H NMR of (2R, 3S)-anti-13 Mannich product 
Reaction conditions: 
Catalyst (mol %): (3S, 5S)-10c (1 mol %) 
Reaction Solvent: Methylene chloride 
Diastereomeric Ratio: 23:1(syn) 
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A.3.2 HPLC Data 
 
 
Figure A.44 HPLC of Mannich reaction by L-Proline (DMSO, 20 mol %) 
Component Retention (Min) Area Height 
(2S,3R)-anti-13 25.933 1579.9795 36.148 
(2S,3S)-syn-13 32.250 44267.7510 702.041 
(2R,3S)-anti-13 57.166 35.4900 0.465 
(2R,3R)-syn-13 66.750 625.3280 4.070 
 
% enantiomeric excess [(2S, 3S)-syn-13] = 97% 
 
(2R, 3R)-syn-13 (2R, 3S)-anti-13 
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Figure A.45 HPLC of Mannich reaction by (3R, 5S)-10c (DMSO, 5 mol %) 
 
Component Retention (Min) Area Height 
(2S,3R)-anti-13 27.983 21211.0710 327.928 
(2S,3S)-syn-13 38.700 4930.1860 64.373 
(2R,3S)-anti-13 61.016 25455.8390 162.035 
(2R,3R)-syn-13 71.383 5331.1760 25.012 
 
% enantiomeric excess [(2R, 3S)-anti-13] = 9% 
 
 
(2S, 3S)-syn-13 
(2R, 3S)-anti-13 
(2R, 3R)-syn-13 
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Figure A.46 HPLC of Mannich reaction by (3R, 5S)-10c (2-PrOH /CH2Cl2, 5 %) 
 
Component Retention (Min.) Area Height 
(2S,3R)-anti-13 25.683 23213.2350 377.139 
(2S,3S)-syn-13 35.483 976.6740 13.276 
(2R,3S)-anti-13 55.500 18418.0645 143.297 
(2R,3R)-syn-13 62.866 989.4590 7.802 
 
% enantiomeric excess [(2S, 3R)-anti-13] = 11% 
 
(2S, 3S)-syn-13 
(2R, 3S)-anti-13 
(2R, 3R)-syn-13 
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Figure A.47 HPLC of Mannich reaction by (3R, 5S)-10c (CH2Cl2, 5 mol %) 
 
Component Retention (Min) Area Height 
(2S,3R)-anti-13 24.916 61760.3780 745.585 
(2S,3S)-syn-13 34.366 2047.8290 27.859 
(2R,3S)-anti-13 53.050 31665.3630 184.096 
(2R,3R)-syn-13 63.983 1945.4390 9.099 
 
% enantiomeric excess [(2S, 3R)-anti-13] = 32% 
 
 
(2S, 3S)-syn-13 
(2R, 3S)-anti-13 
(2R, 3R)-syn-13 
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Figure A.48 HPLC of Mannich reaction by (3S, 5S)-10c (CH2Cl2, 5 mol %) 
 
Component Retention (Min) Area Height 
(2S,3R)-anti-13 29.116 810.1120 11.668 
(2S,3S)-syn-13 38.416 1110.7530 13.839 
(2R,3S)-anti-13 56.183 139337.5780 490.823 
(2R,3R)-syn-13 70.783 4404.7575 13.001 
 
% enantiomeric excess [(2R, 3S)-anti-13] = 99% 
 
 
 
(2S, 3S)-syn-13 
(2R, 3S)-anti-13 
(2R, 3R)-syn-13 
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Figure A.49 HPLC of Mannich reaction by (3S, 5S)-10c (CH2Cl2, 1 mol %) 
 
Component Retention (Min.) Area Height 
(2S,3R)-anti-13 27.916 851.8245 13.523 
(2S,3S)-syn-13 37.883 655.8450 7.777 
(2R,3S)-anti-13 60.616 87811.9000 306.578 
(2R,3R)-syn-13 77.433 2600.3070 13.218 
 
% enantiomeric excess [(2R, 3S)-anti-13] = 98% 
 
 
 
(2S, 3S)-syn-13 
(2R, 3S)-anti-13 
(2R, 3R)-syn-13 
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A.4 Aldol Reaction-1H NMR and HPLC Data 
 
Figure A.50 1H NMR of the Aldol Addition Product  
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Figure A.51 HPLC of Aldol reaction by L-proline, (DMSO, 1 mol %) 
 
Component Retention (Time) Area Height 
(R)-Aldol (Major) 24.4 115814.6770 619.142 
(S)-Aldol (Minor) 36.2 20153.4885 88.884 
 
% enantiomeric excess = 70% (R)-Aldol Product 
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Figure A.52 HPLC of Aldol Reaction by (3S, 5S)-10c (D2O, 10 mol %) 
Component Retention (Time) Area Height 
(R)-Aldol 24.4 63875.0665 619.142 
(S)-Aldol 34.3 63088.0130 88.884 
 
% enantiomeric excess = 0.6% (Racemic) 
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A.5 NMR and HPLC Data of NH-Fmoc S-trityl-Cα-methyl cysteine  
A.5.1 1H NMR Data 
 
 
Figure A.53 1H and 13C NMR data of compound 14 
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Figure A.54 1H and 13C NMR data of compound 15 
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Figure A.55 1H and 13C NMR data of compound 17 
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Figure A.56 1H and 13C NMR data of compound 18 
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Figure A.57 1H and 13C NMR data of compound (R)-19 
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Figure A.58 1H and 13C NMR data of compound 21 
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Figure A.59 1H and 13C NMR data of compound (S)-19 
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A.5.2 HPLC Data 
 
Figure A.60 HPLC of (R)-19 prior to recrystallization 
 
Component Retention (Min) Area Height 
(R)-19 (Major) 6.983 31805.42 1642.371 
(S)-19 (Minor)  9.066 927.342 29.953 
 
Enantiomeric Excess = 94% 
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Figure A.61 HPLC of (R)-19 after recrystallization 
 
Component Retention (Min) Area Height 
(R)-19 (Major) 6.4 42529.43 2311.819 
* Minor Enantiomer-Not Observed 
Enantiomeric Excess = >99% 
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Figure A.62  HPLC of (S)-19 prior to recrystallization 
 
Component Retention (Min) Area Height 
(R)-19 (Minor) 7.2 4161.98 203.036 
(S)-19 (Major) 8.816 100143.3 2949.468 
 
Enantiomeric Excess = 92% 
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Figure A.63 HPLC of (S)-19 after recrystallization 
 
Component Retention (Time) Area Height 
(R)-19 (Minor) 7.35 23.185 0.832 
(S)-19 (Major) 8.966 39545.41 1372.462 
 
Enantiomeric Excess = >99% 
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Figure A.64 Reverse Phase HPLC of Compound (R)-19 
 
Retention time of pure (R)-19 = 35.5 Min 131 
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